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ABSTRACT 
The completion of the Human Genome Project has led us to the next frontier of 
proteomics-understanding functions and structures of the proteome. With an estimated one 
million functionally distinctive proteins, a means for high-throughput analysis, such as protein 
microarray, is required for the identification and quantification of proteins from biological 
samples. Even though protein microarrays have been shown to be a powerful technique for 
proteomics, there are still many challenges involved in building a protein array chip. Some of the 
challenges include finding good protein capture agents with high affinity and specificity, 
choosing an appropriate surface chemistry to immobilize proteins of interest efficiently, 
employing sensitive, fast, and reproducible detection methods, and reducing the amount of non-
specific protein-sensor interactions. To address some of these issues, we employ silicon photonic 
microring resonators, an emerging surface-sensitive analysis method that our group has recently 
utilized for monitoring biomolecular binding and detection in an array-based, label-free 
biosensor format.   
First, aniline-catalyzed hydrazone ligation between surface immobilized hydrazines and 
aldehyde-modified antibodies is shown to be an efficient method to functionalize model oxide-
coated sensor substrates with protein capture agents, allowing derivatization of substrates with 
reduced incubation time and sample consumption. The efficiency of this surface bioconjugation 
at various pHs and in the presence or absence of catalytic aniline was directly evaluated using 
silicon photonic microring resonators. It is found that aniline significantly increases the net 
antibody loading for surfaces functionalized over a pH range from 4.5 to 7.4, resulting in more 
sensitive antigen detection when functionalized microrings are utilized in a label-free 
immunoassay. Furthermore, these experiments also reveal an interesting pH-dependent non-
specific binding trend of antibody that plays an important role in dictating the amount of 
antibody attached onto the substrate, highlighting the competing contributions of the 
bioconjugate reaction rate and the dynamic interactions that control opportunities for a solution-
phase biomolecule to react with a substrate-bound reagent.  
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Some of new emerging capture agents, aptamers and single domain antibodies, are also 
investigated using silicon photonic microring resonators. Binding kinetics of thrombin–binding 
DNA aptamers and a conventional monoclonal antibody against the same target antigen are 
simulatenously evaluated in a multiplexed manner. It is found that the thrombin-binding aptamer 
has a slightly higher affinity constant (KD) than its antibody counterpart. However, we suggest 
that, despite having a ―worse‖ affinity, the thrombin-binding aptamer can be used to quantitate 
the target antigen with a lower limit of detection due to its faster association rate. In a similar 
way, kinetic association and dissociation constants of two single domain antibodies targeting 
ricin toxin are evaluated simultaneously. In this preliminary study, single domain antibodies are 
found to be much more highly specific to ricin as compared to the antibody against the same 
target. Optimization of experimental conditions is still needed to obtain more precise kinetic 
values of ricin capture agents; however, more importantly, we envision that the ability to monitor 
in parallel the binding kinetics of multiple biomolecular interactions on a scalable and cost-
effective platform will be of great utility in evaluating protein binding agents for a range of 
biomedical applications. 
Lastly, perfluoropolymer surfaces‘ wetting properties are controlled using 
nanostructuring of the surface for applications in creating non-fouling surfaces.  The wetting 
properties of the perfluoropolymer, CYTOP, can be easily controlled by changing a few key 
parameters of the reactive ion etching process. With SF6 plasma, even superhydrophobic (contact 
angle higher than 150°) surfaces can be obtained. The Wenzel model and the measured contact 
angles are in good agreement when the surface roughness factors are relatively small.  Unlike 
static contact angles, however, contact angle hysteresis is not improved and furthermore, protein 
non-specific adsorption experiments show that plasma treating CYTOP does not significantly 
improve the material‘s non-fouling properties.  
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Chapter 1 
 
Challenges in Developing Multiplexed Arrays for Protein Detection  
 
1.1. Introduction 
 
Since the completion of Human Genome Project in 2003, proteomics has become one of 
the fast-growing areas in biological research.
1
 Proteomics is not only the study of all proteins in 
terms of sequencing and identification; it is also the study of their functions, structural changes, 
modifications, interactions between them, and, eventually, the cause of diseases.
1-4
 The 
sequencing of the human genome revealed that more than 22,700 genes code for proteins that 
make up the human proteome,
5
 which is more complicated than the genome. It is because the 
proteome of an organism changes over time and physiological conditions, which is essential to 
maintain homeostasis, unlike the genome, which stays constant over time.
3, 6
 The complexity of 
the proteome is generated by a variety of regulatory mechanisms and alternative expression 
strategies.
6
 Among these mechanisms, alternative splicing is considered to be one of the most 
important sources of protein complexity in vertebrates.
7, 8
 Alternative splicing is a regulatory 
mechanism by which the exons, coding regions, are incorporated in a various ways so that 
different forms of mRNAs are generated from the same gene. The preliminary estimates of the 
percentage of genes with alternatively spliced forms (%GASF) in humans range from 35-59%. 
Another source of protein complexity is post-translational modifications.
9, 10
 The properties of 
proteins change either by a proteolytic cleavage or modifications such as phosphorylation, 
glycosylation, acetylation, methylation, etc. As a result of alternative splicing, post-translational 
modifications and other regulation/expression mechanisms, functionally distinctive protein 
numbers are much higher than the number of genes, with an estimated 1 million protein 
structures.
11, 12
 To characterize this large size of the human proteome, which involves the 
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understanding of protein functions, structures, and interactions between them, high-throughput 
analyses are necessary.   
High-resolution 2D-gel electrophoresis mass spectrometry (2 DE-MS) is considered the 
gold standard of proteomic techniques.
6, 13, 14
 Proteins are first separated on a two-dimensional 
gel using isoelectric focusing and then on the basis of molecular weight with a 90 degree 
rotational offset.  Then each spot on the gel is treated with trypsin, and the digested peptides are 
extracted and analyzed by MS. Database searching is then used to achieve protein identification. 
However, low loading capacity and difficulties in separating proteins with extreme pIs, high 
molecular weight, or low abundance have limited the technique.
15, 16
  Liquid chromatography-
based protein separation coupled to MS has been developed as an alternative, and improvements 
in sensitivity and dynamic range have been shown.
15, 17
 Despite the developments in techniques, 
these methods are still time-consuming, expensive, and in need of a significant amount of 
samples, and quantitative information level is low.
1, 6, 11
  
Recently, various protein microarray formats have emerged as powerful tools to solve 
quantitation and high-throughput requirements for proteome analysis.
18, 19
 Macbeath et al. were 
the first to demonstrate the immobilization of proteins at high density in a microarray format 
using robot instrumentation designed for DNA microarrays (Figure 1-1).
20
 Subsequently a wide 
variety of assays have been adapted to protein microarrays for proteomic studies, such as global 
analysis of protein activities,
21, 22
 antibody specificity,
23
 mapping protein interaction networks,
24
 
amongst others. On protein microarrays, capture agents or native proteins are immobilized at 
high density for multiplexed measurements, such as determining abundance or protein-protein 
interactions. Protein microarrays can be classified into two major classes; protein function arrays 
and protein detecting arrays.
18, 25
 The protein function arrays are constructed by immobilizing 
various purified proteins and used to probe a wide range of protein function. Protein-detecting 
arrays are suitable for expression profiling or measuring the level of proteins as specific targets 
are captured by the bound probe with high affinity. Protein microarrays offer many advantages, 
such as the use of small reagent quantities, and measurement efficiency and sensitivity.
26, 27
 
However, it has been proven that making a protein array chip, especially for commercial 
purposes, is much harder compared to DNA chips, and careful consideration must be given to 
the construction of protein microarrays.
19
 There are many challenges involved in building a 
reliable protein microarray. Some of the more prominent factors that I have focused on 
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a)                                                                                                 (b)
 
 
 
 
 
 
 
 
 
 
Figure 1-1. (a) Detecting protein-protein interactions on glass slides. Three pairs of proteins with 
known
 
interactions were chosen; protein G and immunoglobulin G (IgG), p50 and the NF-κB 
inhibitor
 
IκBα, and the FKBP12-rapamycin binding (FRB) domain of FKBP-rapamycin-
associated protein (FRAP) and the human immunophilin
 
FKBP12. The first protein of each pair 
was arrayed on five aldehyde slides and each
 
slide was probed with a different fluorescently 
labeled protein. (A) Slide probed with BODIPY-FL-IgG (0.5 µg/ml). (B) Slide probed with Cy3-
IκBα (0.1 µg/ml). (C) Slide probed with Cy5-FKBP12 (0.5 µg/ml) and 100 nM rapamycin. (D) 
Slide probed with Cy5-FKBP12 (0.5 µg/ml) and no rapamycin. (E) Slide probed with BODIPY-
FL-IgG (0.5 µg/ml), Cy3- IκBα (0.1 µg/ml), Cy5-FKBP12 (0.5 µg/ml), and 100 nM rapamycin. 
In all panels, BODIPY-FL, Cy3, and Cy5 fluorescence were false-colored blue, green, and red, 
respectively. (b) A single slide holding 10,800 spots. Protein G was printed 10,799 times. A 
single spot of FRB was printed in row 27, column 109. The slide was probed with BODIPY-FL-
IgG (0.5 µg/ml), Cy5-FKBP12 (0.5 µg/ml), and 100 nM rapamycin. BODIPY-FL and Cy5 
fluorescence were false-colored blue and red, respectively. Adapted from reference 20. 
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addressing in the course of my research are listed below:  
 
 Protein capture agents: identify and characterize agents which recognize the target 
protein with high affinity and specificity. 
 Immobilization methods: choose an appropriate surface chemistry to immobilize 
proteins of interest efficiently while maintaining their native functionality. 
 Detection methods: employ sensitive, fast, and reproducible detection methods 
 Non-specific adsorption: reduce the amount of non-specific protein-sensor 
interactions  
 
1.2. Protein Capture Agents  
 
One of the hurdles in development of protein microarrays is finding high affinity, well 
characterized protein capture agents.
5, 28
 The role of capture agents is to recognize the target from 
other non-specific proteins in a sample and localize the target throughout the course of the assay 
for the subsequent characterization of bound molecules.
11
 Therefore, good protein capture agents 
must be able to recognize its target with high specificity and high affinity so that even low 
abundant proteins can be efficiently captured. As the role of protein capture agents is so 
important in protein microarrays, the physical nature of the interaction between capture agent 
and target protein often limits the performance of protein microarray itself, regardless of 
detection method. Given the large size of human proteome and the increased need for the high-
throughput proteome analysis,
11
 the development of improved capture agents has become an 
active and important area of research.
28
  
 
1.2.1. Monoclonal Antibodies 
Monoclonal antibodies are the most commonly used affinity capture agents for making 
protein microarrays.
16
 For decades, they have been developed for serial immunoassays, and more 
recently antibodies have been used in multiplexed protein array formats.
25
 Monoclonal 
antibodies ideally have high affinity (equilibrium constants ranging from nanomolar to low 
picomolar) and specificity against targets. Historically, polyclonal antibodies were first produced 
by immunizing laboratory animals and purifying the anti-serum, which contains circulating 
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polyclonal antibodies.
6, 29
 After the development of hybridoma technology, which was first 
described by Kohler and Milstein in 1975,
30, 31
 it became possible to clonally produce identical 
antibodies specific to a target, which are called monoclonal antibodies. Briefly, mice or other 
laboratory animals are immunized with the antigen of interest. After an antigenic response is 
elicited, B cells are isolated from the spleen of the immunized animal. These B cells are fused 
with immortal histocompatible myeloma cells
32
 and incubated on a selective medium containing 
hypoxanthine, aminopterin, and thymidine, otherwise known as ―HAT‖, which allows selective 
proliferation of the B-myeloma hybrid cells. Once selected, a given hybridoma cell line is tested 
for antigen specificity and expanded in culture, which allows for the continued production of a 
particular monoclonal antibody. However, this conventional hybridoma technology is expensive 
and time-consuming, and not incredibly well-suited to the production of monoclonal antibodies 
recognizing the entire human proteome.
28
 Moreover, the resulting antibodies are often unstable 
toward dehydration, pH, thermal variation, and other chemical processes, and lose their activity 
upon immobilization and storage, attributes that conspire to limit the ability of the antibody to 
recognize the target protein.
29
 Furthermore, undesired cross-reactivity and inadequate sensitivity 
often limits the application of antibodies in multiplexed array formats and results in inconsistent 
analytical results (both false-positives and false-negatives).
14, 19
  
To avoid some of the limitations of conventional monoclonal antibodies, other classes of 
protein capture agent strategies have been proposed, such as nucleic acid aptamers,
33-35
 single 
domain antibodies,
36, 37
 multivalent peptide scaffolds,
38-41
 peptoids,
42
 and molecularly imprinted 
polymers.
43
 The rest of this section will discuss aptamers and single domain antibodies, as those 
were utilized in the research described in this thesis.  
The use of monoclonal antibodies as protein capture agents is discussed in Chapters 2-4 
of this thesis. 
 
1.2.2. Aptamers  
Aptamers are oligonucleotides that can bind to a wide range of targets, such as small 
molecules,
44
 drugs,
45
 proteins,
46, 47
 nucleotides,
48
 toxins,
49
 virus,
50
 bacteria,
51
 and cells,
52, 53
 with 
high affinity and specificity. Due to their ability to fold into well-defined three-dimensional 
structure, they are able to bind to their target molecules.
54
  Equilibrium constants of aptamers can 
range from nanomolar to low picomolar, which at times rivals those of monoclonal antibodies.
55
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In 1990, the term ―aptamer,‖ derived from the latin word aptus, which means ‗to fit‘, was first 
coined by the Szostak group from  the Latin.
44
  They isolated RNA molecules binding to a 
variety of organic dyes through multiple rounds of an in vitro selection process. This selection 
process was named the Systematic Evolution of Ligands by EXponential enrichment (SELEX) 
by the Gold lab,
47
 who isolated RNA aptamers against a protein, T4 DNA polymerase, in the 
same year.  
SELEX is an iterative process of in vitro selection and amplification
35, 54, 56
 shown in 
Figure 1-2. In general, the selection of an aptamer begins with the generation of a large pool of 
random single-stranded DNA oligonucleotides using solid-phase phosphoramidite chemistry.
54
 
The DNA sequences typically contain a 30-60 nucleotide variable region and a 15-30 nucleotide 
long fixed region on the 5‘ and 3‘ ends that allow amplification using specific primers and the 
polymerase chain reaction (PCR).
57
 For a high probability of selecting an aptamer, the first round 
of selection starts with a large number of individual sequences, up to about 10
15
.
35, 58
 To generate 
a RNA library, in vitro transcription of DNA oligonucleotides is carried out. After the library 
synthesis, the sequences are exposed to affinity columns modified with the target of interest, and 
sequences with strong affinity are retained while unbound sequences are washed away.
59
  
Alternatively, the separation can be achieved by using capillary electrophoresis (CE), filtration 
using nitrocellulose filters (for proteins) or immunoprecipitation.
54
 Next, bound sequences are 
eluted from the column and amplified by a PCR to enrich the selected sequences for subsequent 
rounds of selection.  For RNA aptamers, the isolated RNA sequences must be converted to DNA 
by reverse transcriptase before conducting PCR. After PCR, in vitro transcription is performed to 
regenerate RNA aptamers. In general, 8-15 rounds of selection and amplification are needed to 
isolated aptamers with high affinity and specificity.
60
 The automated SELEX process was first 
performed by Ellington and 12 rounds of selection were completed in two days in parallel for 
eight selections.
61
  
Aptamers have a number of advantages compared with antibodies that make them very 
promising not only for sensing applications, but also in therapeutic and diagnostic applications.
33, 
58, 62
  One of the main advantages of aptamers is that the selection process is done in vitro so that 
aptamers against virtually any type of target can be generated.
58-60
 Unlike antibodies, selection 
does not require an immunogenic response, and therefore molecules that do not elicit strong  
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Figure 1-2. SELEX process. 1) Synthesis of a library of sequences. 2, 3) Sequences that can bind 
to a target of interest are isolated from a library of sequences by affinity chromatography or by 
other selection methods. 4) The active sequences are amplified by PCR and 5) subjected to 
subsequent rounds of selection in order to enrich for the more active and robust sequences. For 
RNA aptamers, the sequences must be converted into complementary DNAs (cDNAs) prior to 
PCR amplification. Following PCR, in vitro transcription will have to be carried out in order to 
generate the RNA sequences before another round of selection can occur. Adapted from 
reference 54. 
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immune responses, have acute toxicity, or are prohibitively small size can be targeted for the 
limited due to short serum half-life and an immune response against murine monoclonal 
generation of high affinity aptamers. Furthermore, aptamers can be selected under a variety of 
conditions, not limited to physiological pHs or temperature. Stability is another key advantage of 
aptamers that is especially important for applications in protein detection.
57, 58
 Thermally 
denatured aptamers can return to their original conformation without losing binding affinity for 
many cycles, whereas antibodies are temperature sensitive and denaturation is usually 
irreversible. Therefore, aptamer-modified sensors can be reused multiple times. Because 
aptamers are small in size compared to antibodies, it  is also advantageous for sensing 
applications as higher densities of capture agents can be achieved on the surface of devices.
58
 
After the selection process, aptamers are produced by chemical synthesis and purified to a very 
high degree, and as a result, little or no batch-to-batch variations are expected. Moreover, 
reporter molecules, such as fluorescent or recognition tags, can be attached to aptamers at precise 
locations during chemical synthesis, and other modifications can be introduced to further 
improve the stability, affinity, and specificity.
57, 63, 64
  
The use of aptamers as protein capture agents is discussed in Chapter 3 of this thesis. 
 
1.2.3. Single Domain Antibody 
In most of the animals used to generate monoclonal antibodies (mice, rabbits,  goats, rats, 
etc.), antibodies are composed of two heavy chains and two light chains with antigen-binding 
sites formed by the variable domains of heavy and light chains (VH and VL).
65
 On the other 
hand, unusual antibodies found naturally in camelids
36
 and sharks
37
 are composed of only heavy 
chains (Figure 1-3).
66
  Because they are devoid of light chains, antigen-binding sites are formed 
only by a single variable domain (VHH for camelids) of the heavy immunoglobulin chain, and 
the recombinantly produced VHH of these heavy chain antibodies is referred to as single domain 
antibodies.
66, 67
 Structurally the antigen-binding loops of VHH are more variable than those of 
VH, which can be explained in a way that the additional structural freedom was given by the 
absence of VL.
68
  
Single domain antibodies can be generated by phage display technology, which was 
originally developed as an alternative to hybridoma technology, addressing issues of using  
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Figure 1-3. Distinguishing structural features of camelid and shark heavy chain antibodies. 
Conventional Abs composed of heavy (H) and light (L) chains are found in all vertebrates. 
Immunoglobulin domains are depicted as ellipsoid domains. Interchain disulfide bonds are 
indicated by black lines, glycosylation sites as hexagons. The antigen-binding paratope (P) of 
conventional antibodies is formed by the variable domains of heavy and light chains (VH and 
VL), while the paratope of heavy chain antibodies is formed only by the heavy chain variable 
domain, which is designated VHH in camelid hcAbs and VNAR in shark IgNARs. VH and VL 
domains in conventional Abs display hydrophobic binding interactions, while the corresponding 
region in hcAbs is hydrophilic (depicted in pink). Adapted from reference 66. 
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murine monoclonal antibodies for therapeutic purposes.
69
 Since hybridoma technology typically 
generates monoclonal antibodies from immunized mice, the therapeutic use of these antibodies is 
antibodies (patients produce human antimouse-antibodies). Phage display technology
70-72
 was 
first demonstrated in 1985 by George Smith,
70
 and today it is considered to be the most popular 
and well-established technology for the production of human antibodies,
69
 along with another 
technology using transgenic animals.
73
 Phage display begins with the insertion of genes, which 
encode for variable domains of light and heavy chains of antibodies, into the genome of the 
phage capsid proteins. The inserted genes are ligated into gene III or VIII, which encodes minor 
(pIII) or major coat protein (pVIII), located at one end of the phage.
74, 75
  The inserted foreign 
gene is encoded without disrupting pIII or pVIII function and expressed on the phage surface as 
a fusion protein. This generates a library of as large as 10
10
 different peptides
76, 77
 or proteins
71
 
on the surface of filamentous phages, which can then be evaluated using high-throughput 
screening methods. After a panning process, phages with high-binding affinity towards a target 
are selected and the selected phages are cloned. Phage display is a technique to display a large 
library of proteins, and this method can be used to generate single domain antibodies (VHH) 
with sizes as small as 15 kDa.  
Several important advantages of single domain antibodies over standard monoclonals are 
derived from the enhanced hydrophilicity of VHH domains, in contrast to VH domains.
78
 
Specifically, single domain antibodies are highly soluble, which leads to high expression yields 
of the recombinant VHH. Furthermore, they show excellent stability to thermal denaturation,
68
 
which is attributed to efficient refolding of single domain antibodies, also a result of the 
increased hydrophilicity. Due to their small size of about 15 kDa, single domain antibodies can 
also bind to hidden antigenic sites, which are not normally accessible to conventional antibodies 
(150 kDa).
79
 All these properties make single domain antibodies suitable for sensing applications 
as well as therapeutics and diagnostics.  
The use of single domain antibodies as protein capture agents is discussed in Chapter 4 of 
this thesis. 
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1.3. Immobilization Methods 
 
Another challenge in constructing protein microarrays is the attachment of capture 
agents onto the chip surface at high densities while maintaining their function.
19
 To achieve high 
density array format, various microarray printing technologies have been developed mainly in 
two forms; contact printing and non-contact printing.
80, 81
 Contact printing involves direct contact 
between the printing device and the chip surface. A small volume of sample is transferred to the 
tip of the printing device, such as pins, microstamps, and AFM nano-tips, by submerging them in 
a liquid sample and the contact between surfaces and the printing head transfers the fluid onto 
the surface.
82
 To reduce contamination caused by the contact and improve the throughput, 
noncontact printing methods have been developed. Non-contact printing techniques include 
thermal and piezoelectric inkjet printing, and electrospray deposition. 
Even though these printing techniques ensure the deposition of protein solution on a chip 
surface at high densities, the underlying chemistries of surface immobilization need to be 
efficient and allow for localization of capture agents in their active form. Particularly, because 
proteins, unlike DNAs, tend to denature upon chemical treatment and immobilization, it is 
important to choose the immobilization method comparable to structurally diverse  proteins.
26
 
Protein immobilization methods typically include those based on non-covalent interactions or 
covalent ligation (Figure 1-4).
23, 26, 83-85
  These categories can be further subdivided depending 
upon whether the immobilized proteins are randomly or uniformly oriented. Non-covalent and 
non-specific immobilization methods utilize nitrocellulose membranes or polystyrene 
membranes for the physisorption of proteins through electrostatic and hydrophobic interactions. 
The main advantage of this immobilization strategy is that coupling reagents and involved 
modification chemistry are not necessary. However, due to weak and reversible binding 
interactions to membranes, bound proteins can detach from membranes and thus the sensor loses 
activity over time. 
Some non-covalent immobilization methods can also achieve specific orientation of the 
capture site, relative to the surface. These methods adopt well-established affinity tag strategies 
developed for protein purification by column chromatography. Affinity tags, such as biotin, 
hexahistidine, and glutathione-S-transferase (GST), can be genetically encoded to be expressed 
at the N or C termini of the capture agent, allowing immobilization onto surfaces presenting       
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Figure 1-4. Classification of immobilization strategies. (a) Covalent/non-specific attachments 
through a Schiff‘s base. (b) Covalent/site-specific attachments produced through a Staudinger 
ligation (left) and Cu(I)-catalyzed Huisgen cycloaddition (right). (c) Simpler non-covalent/non-
specific attachments through physical/chemical adsorption. (d) Non-covalent/site-specific 
attachments through glutathione/glutathione-S-transferase (left) or avidin/biotin (right) affinity 
hybridizations. Adapted from reference 85. 
 
 
 
 
 
 
 
 (a) (b) 
(c) (d) 
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avidin, nickel nitrilotriacetate, and glutathione, respectively. This immobilization strategy 
provides the advantage of attaching capture agents with a predetermined orientation on the 
microarray, which can result in improvements in capture agent-target binding efficiency. 
However, a major drawback of these methods is the requirement of genetic engineering. 
Conversely, covalent attachment methods that natively present functional groups on the 
capture agent eliminate the need for genetic engineering, and thus they encompass the commonly 
used immobilization methods. Covalent bonds are formed, for example, by amide bond 
formation between primary amine groups of lysine residues and activated carboxylic acids, often 
N-hydroxysuccinimide (NHS) esters, presented by the surface. Several other covalent ligation 
methods such as Schiff‘s base ligation, and imine bond formation are also used in some 
applications.,  The most common approaches used are based upon NHS esters (for amines) and 
maleimides (for sulfhydryls). Unfortunately, both of these reactive groups are unstable in 
aqueous conditions, and the immobilization yield is only modest, as protein attachment competes 
with hydrolysis.
83
 Lastly, chemoselective ligation chemistries based on the use of bioorthogonal 
moieties, such as Staudinger ligation, Cu(I)-catalyzed Huisgen cycloaddition, Diels-Alder 
cycloaddition, and native chemical ligation have been widely explored as covalent/site-specific 
immobilization methods.
84-86
 Even though these methods often require genetic engineering, solid 
phase synthesis, or other pre-immobilization capture agent modification to introduce non-native 
bioorthogonal functional groups to proteins, chemoselective ligation schemes are appealing in 
that they are site-specific and the reactions proceed under mild physiological conditions. 
As is evident from the discussion above, there are advantages and disadvantages of every 
immobilization method. Our group, as well as others, have employed imine ligation
87-93—i.e., the 
reaction between α-effect amines (hydrazine or aminooxy groups) and aldehydes or ketones, as a 
compromise between the generality of reactions at amine groups natively available on proteins 
and the control afforded by chemoselective approaches. More specifically, using a 
commercially-available reagent, an aryl aldehyde functional group is covalently incorporated 
into capture agents via a general succinimidyl ester/amine reaction. The capture agent is then 
conjugated to a surface, which presents hydrazine moiety, by forming hydrazone bonds. 
However, the surface conjugation based on imine bond formation in general is known to be 
relatively slow, thus needs high concentration of capture agents to efficiently functionalize the 
chip surface.
92
 To enhance the efficiency of capture agent immobilization, we have employed 
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aniline-catalyzed hydrazone ligation on sensor surfaces and analyzed the effect of aniline in 
immobilization, as is discussed in Chapter 2. 
 
1.4. Non-Specific Adsorption 
 
Non-specific adsorption of proteins is another formidable challenge for protein detection. 
Many biomolecules (and most proteins) have some tendency to adsorb onto a surface in the 
absence of specific chemical interactions.
94
 Largely due to this type of non-specific adsorption of 
biomaterials, the performance of devices used for biological assays, amongst others, is subject to 
degradation.
95-97
 In the application of protein microarrays and other sensor systems, non-specific 
adsorption typically introduces high background signals that can, in their worst cases, result in 
false positive responses. Protein adsorption processes are complicated and affected by many of 
the chemical and physical properties of surfaces, such as roughness, surface energy, charge, as 
well as the properties of the protein itself.
94
  To address this biofouling problem, researchers 
have invested significant effort in developing fouling-resistant interfaces. Hydrophilic 
poly(ethylene glycol) (PEG) has been widely used to reduce non-specific protein adsorption.
97-99
 
Several factors, such as PEG length and graft density, play important roles in non-fouling, and it 
is believed that polymer steric repulsion, hydration of PEG chains, and entropic polymer chain 
mobility are the key to the resistance properties of PEG.
99, 100
 Surface hydrophobicity is also 
thought to play a major role in biofouling as proteins tend to denature on hydrophobic surfaces. 
However, recently it was shown that superhydrophobic surfaces with a contact angles higher 
than 150° can reduce the amount of protein adsorption.
97, 101, 102
  
Efforts to create superhydrophobic surfaces based upon nanostrucutred 
perfluoropolymer-coated surfaces towards an eventual goal of reducing non-specific protein 
adsorption are discussed in Chapter 5 of this thesis.  
 
1.5. Detection Methods 
 
Detection strategies can be categorized into two classes; label-based and label-free. 
Label-based detection methods require labels, such as fluorescent dyes, chemoluminescent 
15 
 
moieties, or radioisotopes. On the other hand, label-free methods are sensitive to properties 
inherent to the protein to be detected, such as refractive index (RI or n), mass, or charge.
103, 104
 
The most well-established label-based detection methods are based upon fluorescence, 
which is a powerful tool for characterizing the properties of biomolecules down to the single 
molecule level.
105, 106
 Fluorescence-based detection is very sensitive and suitable for the 
detection of proteins over a large dynamic range. However, there are some drawbacks in using 
labels in general. In a protein microarray format, fluorescent labels can be either directly attached 
to the protein of interest, or to a secondary or tertiary recognition element such as in a sandwich 
assay format.
103, 107
 In the case of direct labeling, the main drawback is that the incorporation of 
label itself can introduce structural changes to proteins so that the inherent properties of protein, 
such as binding affinities, can change.
108
 This becomes an especially significant complication 
when it comes to the detection of small proteins or peptides. Moreover, small variations in 
labeling efficiency makes the accurate quantitative measurements difficult.
109
 Indirect labeling 
methods, such as enzyme-linked immunosorbent assays (ELISAs), require secondary antibodies 
recognizing target epitopes, which are different from the ones recognized by the primary 
antibody. Therefore, the capture antibody development time and cost increase significantly. To 
avoid these pitfalls, the development of label-free detection technologies has gained significant 
interests. Silicon photonic microring resonators, surface plasmon resonance imaging (SPRI), 
silicon nanowires, carbon nanotubes, and microcantilevers are some of the examples of these 
new techniques.
103
 Among these, the two most relevant technologies to this thesis, SPRI and 
silicon photonic microring resonators, which our group is pioneering for bioanalytical 
applications, are introduced below.   
 
1.5.1. Surface Plasmon Resonance Imaging (SPRI)  
Surface plasmon resonance imaging (SPRI) or surface plasmon resonance microscopy 
(SPRM) is a promising technique for the multiplexed, label-free detection of biomolecules, such 
as nucleic acids, proteins and carbohydrates.
110, 111
 The operating principle is the same as the 
conventional surface plasmon resonance spectrometry (SPR). Briefly, when the light impinges 
on a thin metal film under certain conditions, such as wavelength and incident angle of light, the 
photon of the light generates surface plasmons, oscillations of free electrons propagating along 
the surface.
112
 Since this resonance condition is sensitive to the changes in refractive index at the 
16 
 
surface of a metal film, the replacement of water (n=1.33) with biomolecules (n=1.4-1.5) near 
the surface alters the resonance condition, and biomolecule bindings and interactions can be 
monitored in a label-free manner.
111
 In SPRI, multiple binding events are imaged simultaneously 
using a CCD detector, and the 2D map of quantitative information can be obtained with a typical 
detection limit of about 10
-6
 refractive index units (RIU), which is about 10-100 times higher 
than that of standard SPR.
113
 While SPRI has not been widely used for multiplexed quantitative 
protein detections (mostly for nucleic acid detection), it is currently being further investigated for 
such applications.
103
  
 
1.5.2. Silicon Photonic Microring Resonators 
Silicon photonic microring resonators belong to a larger class of resonant optical 
microcavities that have recently shown promise for the label-free detection of biomolecules.
114, 
115
 These optical microcavity sensors, which have distinct microcavity geometries, such as 
microtoroids,
116
 microspheres,
117
 microdisks,
118
 and microrings,
119-125
 are waveguide-based, RI-
sensitive detection technologies (Figure 1-5). In general, light from an adjacent linear waveguide 
couples into microcavities, and the circulating optical mode that are supported by the 
microfabricated cavity structures occur under conditions of optical resonance, as defined by:              
                                                                                                                                                                              
where m is an integer value,  is the wavelength of light, and neff is the effective RI that is 
sampled by the optical mode.  
Resonance wavelengths can be determined by the attenuation in transmission through the 
linear waveguide past the cavity, as light is strongly localized on the cavity under conditions of 
optical resonance. From the equation (1-1) above, it is clear that the wavelength that meets the 
resonance condition is sensitive to refractive index, and therefore molecular binding events that 
lead to a chance in the RI near the surface, such as an organic-based biomolecule displacing 
water, can be monitored as a shift in resonance wavelength. By using precise fabrication methods, 
the spectral width of the resonances can be extremely narrow, facilitating the detection of very 
small shifts in the resonance, corresponding to low detection limits. Some of aforementioned 
optical microcavties, such as microtoroids,
116
 and microspheres,
117
 have shown a resolving 
power as sensitive as single binding event level. However, these devices can be challenging to 
fabricate and are prohibitively difficult to optically interrogate, limiting their utility for robust  
17 
 
 
 
Figure 1-5. Different microcavity geometries. Circulating optical modes are highlighted in red 
and the blue indicates the microfluidic flow. Adapted from reference 115. 
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biomolecular detection. Conversely, chip-integrated microring resonators have been 
demonstrated as being highly manufacturable using well-established fabrication methods such as 
deep UV lithography on silicon-on-insulator substrates (Figure 1-6). Furthermore, these 
structures still offer high quality factors (Q≈40,000) and reasonable insertion losses. Based upon 
these advantages, our group has chosen to focus on the development of silicon photonic 
microring resonators as a versatile and multiplexable technology for a wide variety of 
biomolecular detection applications. By functionalizing microring surfaces with proper capture 
agents, we have been able to utilize this sensing platform for quantitative detection of proteins,
121, 
122, 125-127
 and microRNAs
124
 in single- and multiplexed formats in real-time.  
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a) 
 
 
 
 
 
 
 
 
 
(b)    
 
 
 
 
 
 
 
 
 
 
Figure 1-6. Scanning electron microscope images of a silicon photonic microring resonator chip. 
a) An array of 64 microrings on a single chip. A fluoropolymer cladding layer is applied to the 
entire sensor chip and an annular opening surrounding the active microrings is removed via a 
combination of photolithography and reactive ion etching. Sixteen of the rings remain covered 
under cladding layer and are used as thermal controls. As these were not visible in the image, red 
circles have been added to indicate the location of the thermal control rings. b) A high 
magnification image of a single microring showing the annular opening in the fluoropolymer 
cladding layer and the waveguide structures. The adjacent linear waveguide used to couple light 
into this microring is highlighted by the red arrow.  
30 µm 
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2.1. Introduction 
 
Many biomolecular analysis methods rely upon surface-bound capture probes, including 
well-established techniques such as microarrays,
2, 3
 enzyme-linked immunosorbent assays 
(ELISAs), and surface plasmon resonance,
4
 as well as a multitude of emerging optical, electronic, 
and gravimetric analysis technologies.
5
 In all cases and regardless of detection modality, the 
performance of each of these biosensing schemes is impacted by the underlying chemistry that 
links the probe to the sensor surface. Immobilization is particularly critical for proteomic 
applications, where concerns with reagent consumption and capture agent stability are common.
6
 
In general, all bioconjugate schemes for functionalizing biosensor surfaces can be broken 
down into two classes: covalent and non-covalent.
6-9
 Covalent linkages between the capture 
agent and surface are often preferred over non-covalent approaches based upon electrostatic or 
van der Waals interactions on the basis of sensor stability, i.e., non-covalently attached proteins 
can be removed from the surface during a sensing experiment giving an inconsistent response. 
Non-covalent attachment methods that take advantage of high affinity interactions such as biotin-
avidin often have stability comparable to covalent linkages but require addition of non-native 
chemical functionalities that can affect target recognition. 
Covalent functionalization schemes can be further subdivided into two distinct groups 
based upon their requirement for chemical reactive groups that are either native or non-native to 
the protein to be immobilized.
6
 Reactions between appropriately-modified surfaces with free 
amines (from lysines) or sulfhydryls (from cysteines) have been the most widely exploited on 
account of their generality and single-step functionalization. However, these methods encounter 
challenges in that the most common reactive surface groups, succinimidyl esters and maleimides 
for amines and sulfhydryls, respectively, decompose via hydrolysis under conditions optimal for 
biocoinjugation,
7
 meaning that it is difficult to create defined surfaces wherein each immobilized 
capture agent is attached to the surface to a similar extent. In recent years, chemoselective 
ligation chemistries based on the use of bioorthogonal moieties,
10
 such as Staudinger ligation,
11
 
Cu(I)-catalyzed Huisgen cycloaddition,
12
 Diels-Alder cycloaddition,
13
 and native chemical 
ligation,
14, 15
 have been widely explored as immobilization methods, offering exquisite control 
over the extent of chemical ligation between the protein and underlying surface. However, for 
these reactions a non-native chemical functionality must be incorporated into the capture agent 
32 
 
of interest, often involving recombinant expression of non-native proteins or solid phase 
synthesis of modified peptides.
16
 
As a compromise between the generality of reactions at functionalities natively available 
on proteins and the control afforded by chemoselective approaches, our group, as well as others, 
have employed imine ligation
17-25—i.e., the reaction between α-effect amines (hydrazine or 
aminooxy groups) and aldehydes or ketones. More specifically, we have used the commercially-
available reagent, S-4FB, to covalently incorporate an aryl aldehyde group onto antibody capture 
agents via a general reaction of a succinimidyl ester with lysine groups. The antibody is then 
coupled to a surface immobilized 6-hydrazinopyridine installed onto the sensor surface via a 
single-step silanization using a second commercially-available reagent, HyNic silane. An 
advantage of this approach for sensor derivatization is that the succinimide-amine reaction is 
performed in solution and therefore the distribution in number of incorporated aryl aldehydes can 
be regulated and optimized by controlling the excess reagent concentration and solution pH. In 
contrast, succinimide-amine reaction on surfaces, where the succinimide is presented on the 
surface, is more difficult to control due to the competing hydrolysis of the underlying surface, 
which can then become the limiting reagent. However, the rate of imine bond formation and thus 
surface bioconjugation is relatively slow and, in some cases, the capture agent concentration 
required to efficiently derivatize the sensor surface can detract from the advantages of many 
chip-based measurement schemes that typically feature reduced reagent consumption.  
Several recent reports by Dirksen and Dawson describing solution phase reactions have 
illustrated that the rates of imine ligations can be significantly enhanced via the addition of 
aniline, which serves as a nucleophilic catalyst.
20-22
 Under mild conditions the rate constant of 
the reaction in solution can be increased by as much as three orders of magnitude.
19
 In this paper 
we employ the aniline-catalyzed hydrazone ligation reaction for the bioconjugation of a 
representative protein capture agent (antibody) to a silicon oxide biosensor surface using 
commercially available reagents in a simple two-step scheme. We show that this approach is an 
efficient and generally applicable method for immobilizing antibodies onto surfaces for immuno-
based biosensing platforms and highlight an interesting pH dependence on surface conjugation. 
Moreover, we find that the amount of immobilized capture agent depends not exclusively on the 
rate of chemoselective ligation, but also the amount of non-specific interaction between the 
protein capture agent and underlying surface. That is to say that increased non-specific 
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interactions between the proteins and underlying surface, which are pH dependent, provide a 
greater opportunity for the bioconjugate reaction to occur. As a result, we find that for our 
system bioconjugation can be accomplished with relatively high efficiency even at pHs as high 
as 7.4 and with reduced sample consumption when aniline is added, compared to our previous 
report of non-catalyzed imine ligation.
26
 We also compare, under identical pH and antibody 
concentration conditions, the catalyzed hydrazone conjugation scheme to a more conventional 
reaction between the lysine groups of an antibody and surface-bound succinimide esters and find 
that imine ligation represents a superior method for substrate modification. Finally, we compare 
the performance of biosensors functionalized identically with the same capture agent and show 
that the addition of aniline as a nucleophilic catalyst leads to improved sensor performance. 
In this report, chemical and biomolecular functionalization is monitored using silicon 
photonic microring resonators as a model silicon oxide sensor surface. Silicon photonic 
microring resonators are an emerging surface-sensitive analysis method that our group has 
recently utilized for monitoring chemical deposition and biomolecular binding and detection in 
an array-based, label-free biosensor format.
26-29
 This detection platform uses optical interferences 
within ring-shaped silicon waveguide cavities that are extremely sensitive to changes in the local 
refractive index on account of the chemical or biochemical reactions and/or interactions at the 
sensor surface. The addition of biomolecules to the sensor surface leads to changes in microring 
optical properties that are observed as shifts in the resonance frequency of the device, measured 
as an increase in the relative resonance wavelength shift and plotted with units of picometer shift 
that the silicon waveguide is natively passivated with a silicon oxide overlayer and therefore the 
reported results are relevant to many common biosensor substrates, including glass, quartz, and 
many of the other oxide surfaces utilized by micro-electro-mechanical systems (MEMS) 
technologies. 
 
2.2. Experimental Section 
 
2.2.1. Materials 
3-N-((6-(N'-Isopropylidene-hydrazino))nicotinamide)propyltriethyoxysilane (HyNic 
silane) and succinimidyl 4-formylbenzoate (S-4FB) were purchased from SoluLink (San Diego, 
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CA). The 3-aminopropyltriethoxysilane (APTES), was purchased from Gelest (Morrisville, PA). 
Mouse monoclonal anti-(human thrombin) (Cat. # AHT-5020) and human α-thrombin (Cat. # 
HCT-0020) were purchased from Haematologic Technologies Inc. (Essex Junction, VT). 
Vivaspin 500 columns (5 kDa MW cutoff) were purchased from Sartorius (Aubugne, France). 
All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO) and used as received. 
All buffers were made with purified water (ELGA PURELAB filtration system; Lane 
End, UK), and the pH adjusted using 1 M HCl or 1 M NaOH. PBS was reconstituted from 
Dulbecco‘s phosphate buffered saline packets and adjusted to either pH 6.0 or 7.4. Acetate buffer 
was prepared from 50 mM sodium acetate and 150 mM sodium chloride adjusted to pH 4.5. 
Glycine buffer consists of 10 mM glycine and 160 mM NaCl adjusted to pH 2.2. A blocking 
solution containing 2 % (w/v) BSA was prepared by dissolving bovine serum albumin in PBS 
(pH 7.4); BSA-PBS buffer was prepared from this solution by dilution with PBS (pH 7.4) to a 
final concentration of 0.1 mg/mL BSA. BSA solutions were degassed under vacuum before being 
flowed across the sensor surface. 
 
2.2.2. Sensor Substrates and Instrumentation 
Microring resonator sensor chips were designed in collaboration with Genalyte, Inc. (San 
Diego, CA)
26, 30
 and fabricated on 8‖ silicon-on-insulator (SOI, 200 nm thick top-layer Si) wafers 
by the silicon foundry at LETI (Grenoble, France). The entire 8‖ wafer was spin coated with a 
fluoropolymer cladding material and the cladding removed from individual microrings via 
photolithography and reactive ion etching. The 6 x 6 mm chips with an array of 64 microrings 
measuring 30 μm in diameter were diced from the 8‖ wafers by Grinding and Dicing Services, 
Inc. (San Jose, CA). Linear waveguides having input and output diffractive grating couplers at 
either end were located next to the microrings, allowing for the optical properties of each 
microring to be interrogated independently. Light from the linear waveguide is coupled into the 
microring cavity through the evanescent field, and resonance is observed when the resonance 
condition is satisfied. 
Instrumentation enabling measurement of resonance frequency shifts for the microring 
resonators was purchased from Genalyte, Inc..
26, 30
 Briefly, a tunable beam from a diode laser 
with a center frequency of 1560 nm is rapidly rastered across the sensor chip, and the beam is 
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focused onto a single input coupler. The light projected off the output coupler is measured at the 
photodetector and the resonance is detected as a minimum in intensity of the output at a given 
wavelength. This current configuration allows up to 32 microring resonators to be individually 
addressed, eight of which are not exposed to test solutions (i.e., under the cladding layer) and 
serve as controls for thermal drift. Solutions are introduced through two inlets in a custom Teflon 
lid that delivers liquids across to the sensor chip through two microfluidic channels defined by a 
laser cut Mylar gasket (fabricated by RMS Laser; El Cajon, CA) via negative pressure applied by 
syringe pumps (11 Plus syringe pump, Harvard Apparatus; Holliston, MA). 
 
2.2.3. Surface Functionalization and Antibody Attachment 
Sensor chips were cleaned with piranha solution (3:1 H2SO4:30%H2O2)
31
 for 3 minutes to 
remove any organic contaminants, rinsed with copious amounts of distilled (DI) water, and dried 
under nitrogen. Microring substrates were then loaded into the described Teflon cell and Mylar 
gasket microfluidic device and functionalized by exposure to 1 mg/mL HyNic silane solution in 
95% ethanol and 5% DMF at 5 μL/min for 30 min, followed by rinsing with 100% ethanol. 
A solution containing 100 μg of anti-(human thrombin) was buffer-exchanged into PBS 
(pH 7.4) using Vivaspin 500 spin columns. A 5-fold molar excess of S-4FB solution (2 mg/mL 
stock) was added to the antibody solution (~0.3 mg/mL) and the reaction mixture allowed to 
incubate for 3 h. Following the incubation, unreacted S-4FB was removed by buffer-exchanging 
into the appropriate working pH buffer (e.g., 4.5, 6.0, or 7.4) using Vivaspin 500 spin columns. 
Conjugation solutions were prepared with 5 μg/mL (33 nM) 4FB-modified antibody both with 
and without 100 mM aniline as a nucleophilic catalyst at each of the three different pHs. 
Sensor functionalization was monitored by flowing the S-4FB-modified antibody 
solution over HyNic-modified microring resonators at a rate of 30 μL/min, 150 μL/min, and 6 
μL/min for 30 min and recording the shift in resonance wavelength as a function of time. A two-
channel gasket was employed to observe surface conjugation simultaneously in the presence or 
absence of 100 mM aniline, with one channel presenting aniline- and antibody-containing 
solution to the substrate and the other channel filled with a catalyst-free antibody solution. The 
buffer used for obtaining background measurements and rinsing was adjusted to mimic the 
presence or absence of aniline in the respective conjugation solutions to eliminate bulk refractive 
index differences upon solution switching. By doing this, observed shifts in resonance 
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wavelength can be attributed solely to surface bioconjugation. After a 30 min reaction time for 
hydrazone bond formation between HyNic presented on the surface and S-4FB moiety on the 
antibody, the flow chamber and microrings were rinsed with PBS buffer for 20 min, followed by 
a 2 min exposure to a low pH glycine buffer (pH = 2.2) in order to remove any non-covalently 
attached antibody.  
For succinimidyl ester attachment of antibody onto microring surfaces, the sensor surface 
was first exposed to a 2 % (v/v) solution of APTES in 95 % ethanol at 5 µL/min for 60 min, 
followed by rinsing with 95 % ethanol to remove any residual silane. Anhydrous DMF 
containing 100 mM N,N-diisopropylethylamine and 100 mM N,N'-disuccinimidyl carbonate was 
then flowed over the amine modified microring surface at 5 µL/min for 3 h, and rinsed with 
anhydrous DMF containing 100 mM N,N-diisopropylethylamine for 20-30 min, followed by 95% 
ethanol for 10-20 min. Shortly after switching to PBS (pH 7.4), the microring surface was 
exposed to 5 µg/mL anti-(human thrombin) in PBS (pH 7.4) for antibody functionalization. After 
30 min incubation at 30 µL/min, the sensor surface was rinsed with PBS buffer for 20 min, 
followed by a 2 min exposure to glycine buffer (pH = 2.2) to remove any non-covalently 
attached antibody. 
 
2.2.4. Antigen Detection 
Following antibody conjugation the microring surfaces were blocked with 2 % (w/v) 
BSA in PBS (pH 7.4) in order to reduce non-specific protein adsorption in subsequent antigen 
detection experiments. A 4-μL aliquot of 8.3 mg/mL solution of human α-thrombin was buffer 
exchanged to BSA-PBS using Vivaspin 500 spin columns. Working solutions containing 20 nM, 
5 nM, 2 nM, and 0.5 nM antigen in BSA-PBS were prepared by successive dilution of a 1 μM 
stock solution. These solutions were then flowed over the antibody-functionalized sensor chips at 
30 μL/min for 10 min as antigen association was monitored, followed by a BSA-PBS rinse for 20 
min to observe antigen dissociation. The surface was then regenerated by flowing glycine buffer 
for 2 minutes followed by 10 min in BSA-PBS to re-establish baseline for subsequent detection 
experiments. 
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2.2.5. Data Processing 
Sensor microring data was corrected for drift related to thermal and instrumental 
fluctuations by normalizing against the response of reference microrings—those (four microrings 
in each channel) that were kept under the fluoropolymer cladding, unexposed to solution. Offline, 
residual slope as well as offset of the baseline were corrected, and data aligned temporally at the 
point when antibody or antigen was introduced. 
 
2.3. Results and Discussion 
 
The general imine reaction used to couple a representative protein capture agent, a mouse 
monoclonal anti-(human thrombin) antibody, to the microring silicon oxide surface is shown in 
Figure 2-1. In parallel, the silicon oxide surface is modified with HyNic silane to install 
hydrazine moieties (Figure 2-1a), while aromatic aldehydes are incorporated onto antibodies 
(Figure 2-1b) in a controlled manner via reaction with succinimidyl 4-formylbenzoate (S-4FB). 
The modified-antibody is then flowed across the HyNic surface at various pHs and in the 
presence or absence of aniline to enable bioconjugation (2-1c). In the presence of aniline, a more 
reactive Schiff base, 3, is formed (Figure 2-1b) that is more easily protonated under mildly acidic 
conditions than the starting carbonyl; this results in the acceleration of hydrazone ligation via 
transimination.
21, 22
 
A key attribute of the microring resonator analysis platform is that it enables real time, 
label-free monitoring of chemical and biomolecular reactions and interactions that occur on the 
surface of the microring. This feature allows visualization of each step involved in surface 
conjugation on our model silicon oxide biosensor substrate. Figure 2-2 shows the real-time shift 
in resonance wavelength for ten microrings simultaneously exposed to a 1 mg/mL HyNic silane 
solution; the first surface reaction shown in Figure 2-1a. It is worth mentioning here that HyNic 
silane is an effective and more convenient method of installing hydrazine moieties on the silicon 
oxide microring surface, compared to our previous sequential two step functionalization 
involving addition first of APTES followed by S-HyNic (succinimidyl 6-hydrazinonicotinamide 
acetone hydrazone).
26, 27
 Specifically, the reaction time has been significantly reduced from 
several hours to 30 min and we have found sensor functionalization to be much more 
reproducible. 
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Figure 2-1. Surface reaction scheme for conjugating antibodies onto oxide-passivated silicon 
photonic microring resonators via hydrazone ligation. (a) 3-N-((6-(N'-
Isopropylidenehydrazino))-nicotinamide)propyl triethyoxysilane (HyNic silane) is immobilized 
onto the silicon/silica surface. (Note that the free hydrazine is protected as an acetone hydrazone, 
1.) (b) In parallel, proteins are modified with succinimidyl 4-formylbenzoate (S-4FB) via their 
primary amines, 2; and, if added, aniline forms a Schiff base, 3. (c) The 4FB-modified protein is 
conjugated to the HyNic-modified silicon/silica surface via the transimination of the Schiff base 
with the hydrazine to form the hydrazone linkage, 4. 
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Figure 2-2. Real-time monitoring of the shift in resonance frequency for ten microrings within 
the same sample flow chamber during organic modification via reaction with HyNic silane. The 
chamber was initially filled with 100% ethanol and a solution of 1 mg/mL HyNic silane in 95% 
EtOH and 5% DMF introduced under flow (5 L/min) at t = 8 min. After 30 min, the HyNic 
silane was flushed from the chamber and microrings returned to 100% ethanol. The residual 
wavelength shift corresponds to immobilized HyNic silane. 
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Following silanization, the 4FB-modified antibody is flowed across the HyNic-
functionalized microring surface and the amount of antibody localized at the sensor surface is 
monitored in real time as a shift in resonance wavelength. Figure 2-3 shows real-time 
wavelength shifts as 4FB-modified anti-(human thrombin) antibody is introduced over HyNic-
modified surfaces at three different pHs either in the presence (Figure 2-3a) or absence (Figure 
2-3b) of aniline. To simplify the graphical display of the data, the response of single ring, which 
is representative to the average response of all the microrings (n = 10-12 for all measurements), 
was chosen for inclusion in Figure 2-3. The first key observation in comparing these 
bioconjugate reactions in the presence or absence of the nucleophilic catalyst (Figure 2-3a vs. 
Figure 2-3b) is that for all pHs the total amount of immobilized antibody is significantly 
increased in the presence of aniline, as indicated by larger resonance wavelength shifts. By 
comparing the net peak shifts measured after the glycine rinse to remove non-covalently bound 
protein (Table 2-1), average antibody loading is improved with the addition of aniline by a factor 
of 7.2 at pH 4.5, 3.2 at pH 6.0, and 14.8 at pH 7.4. Furthermore, for the aniline-catalyzed 
reactions (Figure 2-3a) the amount of covalently bound antibody increases with decreasing pH, 
consistent with previous reports of enhanced solution reaction rates at lower pHs.
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Recently, we empirically determined the relationship between the amount of bound mass, 
determined via radioimmunoassay, and resonance wavelength shift measured from our microring 
resonators.
33
 Using the resultant conversion factor, 14.7 (pg/mm
2)/Δpm, we are able to convert 
the observed antibody loadings into relative surface coverage in terms of both mass per unit area 
and area per antibody. We find that when aniline is used as a catalyst, antibody loadings up to 
6.4 ± 0.3 ng/mm
2
 (39 nm
2
/antibody) can be achieved, while the best non-catalyzed loading is 
only 1.6 ± 0.5 ng/mm
2
 (150 nm
2
/antibody). For reference, the theoretical maximum coverage for 
antibodies arranged in the most space efficient edge-on orientation is 34 nm
2
/antibody,
34
 
meaning that the aniline-catalyzed method described in this paper is able to achieve 87% of the 
maximal loading. However, for optimal biomolecular recognition, the edge-on orientation would 
not be ideal and thus a compromise must be struck between loading density and antibody 
activity—a balance that will likely vary for each antibody and depend on the eventual application 
of the modified substrate.
35
 
Returning to the non-catalyzed reaction (Figure 2-3b), the pH-dependence does not 
appear to be as straightforward as it is in the case of the catalyzed reaction, as pH 6.0 gives the  
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Figure 2-3. Real-time shifts in resonance wavelength from representative microrings upon 
covalent immobilization of anti-(human thrombin) antibody onto the sensor surfaces at three 
different pHs and in the presence (a) and absence (b) of 100 mM aniline. In each trace the 
sensors were initially incubated in buffer (with or without aniline, respectively) at a flow rate of 
30 μL/min and a 5 μg/mL solution of 4FB-modified antibody with or without 100 mM aniline 
was flowed for 30 min. After switching back to the original buffer for 20 minutes, non-
covalently attached antibody was removed with a low pH (pH 2.2) glycine buffer rinse. The 
sensors were then returned to the respective buffer at t = 57 min to determine the residual net 
shift corresponding to the amount of covalently immobilized antibody. 
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Table 2-1. Summary of peak shifts before and after glycine rinse at all pH conditions and the 
estimated immobilized antibody density 
 
pH (# of 
rings) 
Peak shift 
before 
glycine rinse 
(pm) 
Peak shift after 
glycine rinse 
(pm) 
Estimated 
immobilized 
antibody density 
(ng/mm
2
) 
Estimated 
area/antibody 
(nm
2
/antibody) 
Without 
aniline 
4.5 (n=12) 72.4 ± 8.7 60.6 ± 8.8 0.9 ± 0.13 280 ± 40 
6.0 (n=12) 139.6 ± 37.0 111.3 ± 37.4 1.6 ± 0.5 150 ± 50 
7.4 (n=11) 102.8 ± 27.8 20.4 ± 20.4 0.3 ± 0.3 800 ± 800 
With 
aniline 
4.5 (n=10) 443.4 ± 21.8 437.5 ± 21.7 6.4 ± 0.3 39 ± 2 
6.0 (n=12) 371.3 ± 8.2 358.6 ± 8.3 5.3 ± 0.12 47 ± 01 
7.4 (n=11) 329.1 ± 12.4 302.6 ± 10.2 4.4 ± 0.15 56 ± 2 
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largest resonance wavelength shift after glycine rinse followed by 4.5 and 7.4, respectively. To 
understand this discrepancy we focus on the difference in resonance wavelength shift before and 
after the low pH glycine rinse, which is used to remove proteins that are non-covalently bound to 
the surface. Interestingly, the amount of antibody removed by the glycine rinse increases 
dramatically with increasing pH—relative resonance wavelength shift decreases of 16.5 ± 2.6 % 
(n=12), 21.8 ± 6.0 % (n=12), and 82.8 ± 12.3 % (n=11) for pH 4.5, 6.0, and 7.4, respectively—
revealing a significant pH-dependence of non-specific adsorption. Furthermore the pH-
dependence of non-specific adsorption is opposite that of the hydrazone bond formation reaction, 
which leads to the complex relationship between pH and amount of covalently bound antibody. 
While the reaction is more efficient at lower pH, proteins have less of an opportunity to react 
with the surface due to reduced residence time at the sensor surface. This is in contrast to the 
purely solution phase situation where yield is predominantly dictated by reaction rate. When one 
of the reactants is bound to a substrate then the other reactant is required to interact with the 
surface, a process that for biomolecules is often accomplished via non-specific and initially non-
covalent adsorption. This preadsorption helps increase the amount of protein on the surface that 
is available to react.
36-38
 Once bound, the rate of the bioconjugate reaction helps dictate the 
overall amount of antibody loading, hence the reduction in antibody desorption after glycine 
rinse at lower pHs, which follows the same pH dependence observed in free solution.
20-22
 
Returning to the data in Figure 2-3b, at pH 7.4 a large amount of antibody initially non-
covalently binds to the substrate, but the reaction is so inefficient that it is almost entirely 
removed with the glycine rinse. By contrast, a reduced amount of protein initially binds at pH 4.5, 
but the enhanced reaction rate (even in the absence of aniline) leads to a greater amount of 
covalently attached antibody and a larger net resonance wavelength shift after glycine. This 
model, which involves a competition between reaction rate and non-specific binding, is also 
observed for the aniline-catalyzed hydrazone ligations (Figure 2-3a), with bound antibody losses 
after glycine rinse of 1.3 ± 0.4 % (n=10), 3.4 ± 0.4 % (n=12), and 8.0 ± 2.3 % (n=11) observed 
for pH 4.5, 6.0 and 7.4, respectively. Again, more non-covalently adsorbed antibody is removed 
from surfaces conjugated at higher pHs where the reaction rate is reduced; however, the addition 
of aniline significantly increases the rate of reaction at all pHs such that net losses of bound 
protein are significantly reduced, as compared to the non-catalyzed reaction. Furthermore, 
aniline catalyzed reactions at 150 μL/min and 6 μL/min were measured to investigate the effect 
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flow rate during antibody immobilization (Figure 2-4). For these additional flow rates, the pH 
dependent trend in antibody loading and the percent loss of bound antibody after glycine rinse is 
consistent, but the overall responses are, in both cases, smaller than those observed for 30 
μL/min. 
Beyond just comparing catalyzed versus non-catalyzed hydrazone ligation, we also 
investigated the efficiency of the often used succinimidyl ester/amine (lysine) conjugation 
chemistry. Unmodified antibody was flowed across succinimidyl ester presenting microrings 
after the surface was modified with APTES followed by N,N'-disuccinimidyl carbonate. While 
this conjugation reaction is similar in efficiency to that of the non-conjugated hydrazone ligation 
at the optimal condition (pH = 6.0), aniline catalyzed imine ligation is superior at all pHs, 
showing at least a 3-fold improvement in antibody loading (Figure 2-5a). Using the conversion 
factor between resonance wavelength shift and bound mass, we can determine that the 
succinimidyl ester scheme, under the described conditions, yields an antibody coverage of ~1.7 
ng/mm
2
. 
To demonstrate the improvement in sensor response resulting from the effective aniline-
catalyzed functionalization of the microring with an antibody capture agent, we monitored the 
interactions between human α-thrombin and the sensor surface. These experiments not only 
verify that the immobilized antibodies are still functional but also facilitate direct comparison of 
sensor responses from microrings bioconjugated in the presence or absence of aniline. 
Microrings functionalized with antibody both in the presence and absence of aniline and 
at all three pHs were exposed to solutions of human α-thrombin at various concentrations 
ranging from 0.5 to 20 nM. Figure 2-6 shows the real time shifts in resonance wavelength upon 
the introduction of thrombin across microrings functionalized with anti-(human thrombin) 
antibodies immobilized at pH 7.4 in the presence (Figure 2-6a) and absence (Figure 2-6b) of 
aniline. Notably, a strong, concentration-dependent sensor response is observed for microrings 
functionalized in the presence of aniline. Conversely, the binding of thrombin is hardly 
detectable even at the highest concentrations when flowed across microrings functionalized in 
the absence of aniline at pH 7.4. Thrombin detection for sensors functionalized with antibody at 
pH 6.0 and 4.5 (Figures 2-7 and 2-8) show similar results. At all pHs microrings functionalized 
in the presence of aniline displayed stronger responses to the antigen; however, the relative  
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Figure 2-4. Real-time shifts in resonance wavelength from representative microrings upon 
covalent immobilization of anti-(human thrombin) antibody onto the sensor surfaces at three 
different pHs in the presence of 100 mM aniline at 150 μL/min (a) and 6 μL/min (b). In each 
trace the sensors were initially incubated in buffer (with or without aniline, respectively) and a 5 
μg/mL solution of 4FB-modified antibody with 100 mM aniline was flowed for 30 min. After 
switching back to the original buffer for 20 minutes, non-covalently attached antibody was 
removed with a low pH (pH 2.2) glycine buffer rinse. The sensors were then returned to the 
respective buffer at t = 57 min to determine the residual net shift corresponding to the amount of 
covalently immobilized antibody. 
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Figure 2-5. (a) Thrombin antibody immobilization on the succinimidyl ester modified surface 
(black) and 4FB-modified antibody immobilization on the HyNic presented surface in the 
presence of aniline (red). In each trace the sensors were initially incubated in buffer (PBS at pH 
7.4 or 100 mM aniline in PBS at pH 7.4, respectively) and a 5 μg/ml solution of unmodified or 
4FB-modified antibody was incubated for 30 min. After buffer rinse (20 min), any non-
covalently attached antibody was removed by a rinse with low pH (pH=2.2) glycine buffer; (b) 
Detection of human α-thrombin using microrings modified with antibody at pH 7.4 by 
succinimidyl ester/amine conjugation (black) and aniline-catalyzed hydrazone ligation (red). The 
microrings are initially in BSA-PBS buffer and thrombin is introduced at t = 5 min. Following 10 
min incubation with thrombin, the flow cell is rinsed with BSA-PBS to observe antigen 
dissociation.  
0 10 20 30 40 50 60 70
-100
0
100
200
300
400
500a)
 succinimidyl ester/amine conjugation
 aniline-catalyzed hydrazone ligation
R
e
la
ti
v
e
 s
h
if
t 
(
p
m
)
Time (min)
glycine
antibody 
(5 ug/ml)
buffer
buffer
0 5 10 15 20 25 30 35
-5
0
5
10
15
20
25
BSA-PBS
-thrombin
BSA-PBS
b)
R
e
la
ti
v
e
 s
h
if
t 
(
p
m
)
Time (min)
47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-6. Time-resolved response from human α-thrombin binding to microrings modified 
with anti-(human thrombin) antibody at pH 7.4 in the presence (a) and absence (b) of 100 mM 
aniline. The microrings are initially in BSA-PBS buffer and thrombin is introduced at t = 5 min. 
Thrombin is then introduced and incubated for 10 min, after which BSA-PBS buffer is flowed to 
observe antigen dissociation. The remaining antigen-antibody interactions on the surface are then 
disrupted via exposure to a low pH (pH 2.2) glycine buffer for 2 min (not shown) to regenerate 
the sensor for subsequent detection experiments. 
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Figure 2-7. Time-resolved detection of human α-thrombin using microrings modified with anti-
(human thrombin) antibody at pH 6.0 in the presence (a) and absence (b) of aniline. Following 
10 minutes exposure to thrombin, the antibody surface was rinsed with BSA-PBS for 20 minutes 
and regenerated by exposure to glycine buffer for two minutes before returning to BSA-PBS. 
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Figure 2-8. Time-resolved detection of human α-thrombin using microrings modified with anti-
(human thrombin) antibody at pH 4.5 in the presence (a) and absence (b) of aniline. Following 
10 minutes exposure to thrombin, the antibody surface was rinsed with BSA-PBS for 20 minutes 
and regenerated by exposure to glycine buffer for two minutes before returning to BSA-PBS. 
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difference in signal is most pronounced at pH 7.4, where the difference in antibody loading in the 
catalyzed versus non-catalyzed reactions is largest. 
For our application, the enhanced efficiency of aniline-catalyzed bioconjugation coupled 
with the interesting pH dependence of non-specific interaction allows us to effectively 
functionalize biosensor surfaces for shorter times and with less antibody consumption (~30 
pmoles). It also permits bioconjugation at neutral pHs, which is advantageous for some proteins 
over to the lower pHs where the solution-phase hydrazone ligation is most efficient. The relative 
extents of the competing effects of non-covalent adsorption and bioconjugation will clearly vary 
as a function of many factors, including underlying surface charge (electrostatics) and relative 
hydrophobicity (van der Waals interactions), but this paper highlights an interesting interplay 
between reaction rate and opportunity for surface interaction, perhaps by non-specific adsorption, 
as both play important roles in dictating the efficiency of surface bioconjugation and therefore 
should be considered in concert for process optimization. 
 
2.4. Conclusion 
 
Aniline-catalyzed hydrazone ligation is shown to be an efficient method for attaching 
protein capture agents to a model silicon dioxide surface. Using silicon photonic microring 
resonators as a label-free, real-time surface analysis tool we demonstrate that substrate 
functionalization is improved across a broad pH range when aniline is added as a nucleophilic 
catalyst. Importantly, we show an important pH-dependent role that non-covalent protein 
adsorption plays in dictating the overall antibody loading. A role that in our system allows 
efficient functionalization of biosensor surfaces with reduced sample consumption, incubation 
time, and at neutral pH. We anticipate that aniline catalyzed hydrazone ligation will become a 
useful tool in a wide range of surface biofunctionalization applications which include, amongst 
others, quantitative antigen detection and target-specific immunocapture/depletion. 
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Multiplexed Evaluation of Capture Agent Binding Kinetics Using 
Arrays of Silicon Photonic Microring Resonators 
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Capture Agent Binding Kinetics Using Arrays of Silicon Photonic Microring Resonators.‖ 
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3.1. Introduction 
 
 Common to most quantitative protein measurement approaches is a requirement for 
analyte-specific capture agents that recognize, and in many cases localize, the target antigen 
allowing specific detection via one of many biomolecular transduction technologies.
2
 
Regardless of the eventual detection modality, the physical nature of the interaction between 
capture agent and target protein often represents the fundamental limitation in assay 
sensitivity. With the goal of quantitating an ever increasing breadth of the proteome, the 
development of new and improved capture agents has become an active area of research.
3-5
 
  Monoclonal antibodies are the most commonly used capture agents for protein 
detection.
6, 7
 A high-quality antibody ideally has good binding specificity and high-affinity 
(equilibrium constants ranging from nanomolar to low picomolar) to its target protein. 
However, as discussed in Chapter 1, producing monoclonal antibodies by conventional 
hybridoma technology
8
 is expensive, time-consuming and labor-intensive.
9
 Furthermore, the 
resulting antibodies are often unstable towards dehydration, pH and thermal variation, and 
other chemical processes, which compromise protein secondary and tertiary structure. In a 
multiplexed array format, in particular, cross-reactivity and inadequate sensitivity become an 
issue as this results in false-positives and negatives 
10, 11
 To avoid limitations associated with 
antibodies, a range of alternative protein capture agent strategies have been proposed, 
including nucleic acid aptamers,
12-14
 single domain antibodies,
15, 16
 multivalent peptide 
scaffolds,
17-20
 peptoids,
21
 and molecularly imprinted polymers,
22
 amongst others. Many of 
these alternative strategies improve upon the throughput of agent generation by replacing 
animal immunization and hybridoma generation with high-throughput methodologies such as 
ligand evolution (e.g. SELEX)
14
 and solid-phase library synthesis. Similarly to combinatorial 
drug discovery,
23
 these methods should be capable of generating libraries of ―lead‖ capture 
agents against single analytes and the binding characteristics of each member will need to be 
independently determined. For purposes of assay consistency and antigen conservation, it 
would be ideal if capture agent evaluation could be carried out in parallel, establishing a need 
for multiplexable capture agent screening methods. 
 The most common quantitative metric used to describe the interaction between a 
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capture agent and its target antigen is the equilibrium dissociation constant, KD. Classically, 
KD is determined via radioimmunoassay,
24
 but more common now are kinetic methods that 
allow measurement of association and dissociation rate constants, ka and kd, from which KD is 
computed (KD=kd/ka). Real-time interaction analysis tools such as surface plasmon resonance 
(SPR)
25
 have been successfully applied to binding affinity determination,
26
 but a need still 
remains for highly multiplexable capture agent evaluation technologies. In this study, silicon 
photonic microring resonator system was employed to simultaneously evaluate multiple 
capture agents against the same target. As discussed in Chapters 1 and 2, the binding of 
antigens to capture agents covalently attached to the microring changes the effective 
refractive index of the optical mode, eliciting a corresponding shift in the resonant 
wavelengths, as shown in Figure 3.1. These shifts can be monitored in real time, allowing 
visualization of biomolecular interaction kinetics. 
 In order to demonstrate the applicability and versatility of this platform for multiplexed 
capture agent screening, we wanted to evaluate two different classes of capture agents that both 
recognize the same target antigen. To accomplish this, we chose to interrogate a monoclonal 
mouse anti-human thrombin antibody and a 15-nucleotide long aptamer that also recognizes 
human thrombin.
27
 Aptamers are single-stranded nucleic acids that can bind to their targets with 
high affinity and specificity.
28
 Aptamers against a wide range of targets, such as small 
molecules,
29
 antibiotics,
30
 proteins,
27, 31
 nucleotides,
32
 toxins,
33
 virus,
34
 bacteria, 
35
 and cells
36, 37
 
have been isolated through an in vitro selection process, SELEX. Aptamers are considered to 
rival conventional antibodies in many aspects.
12, 38, 39
  The binding affinity of aptamers can be 
comparable to those of antibodies, and they can be selected against virtually any type of target 
because the selection process takes place in vitro.
38, 40, 41
 Aptamers are produced by chemical 
processes after the selection, batch-to-batch consistency is guaranteed, and chemical 
modification is relatively easy. Furthermore, they are stable over temperature change and 
denature conditions.
38, 42-44
 Due to these advantages, amongst others, aptamers have found utility 
in a range of biomolecular assays.
38, 45
 In this study, both the antibody and aptamer were 
covalently immobilized onto different regions of the sensor array and their respective 
interactions with identical thrombin solutions were simultaneously interrogated. 
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Figure 3-1. (a) Schematic diagram illustrating the principle of silicon photonic microring 
resonators presenting aptamer capture probes and target antigen binding. (b) A representative 
transmission spectrum showing a shift in the resonance wavelength upon a target binding, 
and (c) an illustration of real-time monitoring of wavelength shifts during a target binding. 
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3.2. Experimental Section 
 
3.2.1. Materials 
3-N-((6-(N'-Isopropylidene-hydrazino))nicotinamide)propyltriethyoxysilane (HyNic 
silane) and succinimidyl 4-formylbenzoate (S-4FB) were purchased from SoluLink (San Diego, 
CA). Aniline was obtained from Acros Organics (Geel, Belgium), and proteinase K was 
purchased from USB (Cleveland, OH). Mouse monoclonal anti-(human thrombin) (Cat. # AHT-
5020) and human α-thrombin (Cat. # HCT-0020) were purchased from Haematologic 
Technologies Inc. (Essex Junction, VT). HPLC purified thrombin-binding aptamer and a control 
DNA sequence were purchased from Integrated DNA Technology (Coralville, IA). The full 
sequences are as follows. 
Thrombin-binding aptamer: 5′–NH2–(CH2)12–2CHNTGGTTGGTGTGGTTGG-3′ 
Control sequence: 5ontr2–(CH2)12–2CHrol sequence: TGG-3′:TATAAGATT-3u 
Vivaspin 500 columns (5 kDa MW cutoff) were purchased from Sartorius (Aubugne, France). 
All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO) and used as received. 
All buffers were made with purified water (ELGA PURELAB filtration system; Lane 
End, UK), and the pH was adjusted with 1 M HCl or 1 M NaOH. PBS was reconstituted from 
Dulbecco‘s phosphate buffered saline packets and adjusted to either pH 6.0 or 7.4. Glycine buffer 
consists of 10 mM glycine and 160 mM NaCl adjusted to pH 2.2. A blocking solution containing 
2 % (w/v) BSA was prepared by dissolving bovine serum albumin in PBS (pH 7.4) and it was 
degassed under vacuum before being flowed across the sensor surface. Tween-PBS buffer was 
prepared by adding 0.05% (v/v) Tween 20 in PBS (pH 7.4). Tris buffer consists of 50 mM Tris-
HCl, 100 mM KCl, and 5 mM CaCl2 adjusted to pH 7.4, and proteinase K (0.1 mg/ml) solution 
was prepared using Tris buffer.  
 
3.2.2. Sensor Substrates and Instrumentation 
The microring resonator sensor chips and measurement instrumentation used were 
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identical to that described in Chapter 2 and in the literature. 
46, 47
 Sensor chips are loaded into a 
custom Teflon cell with microfluidic channels defined by a Mylar gasket (fabricated by RMS 
Laser; El Cajon, CA), which allow either two or four separate solutions to be directed to different 
regions of the sensor array. Previously we used two microfluidic channel designs that had two 
unique channel flow patterns. However, in this study we utilized a new design (courtesy of Mr. 
Jared Kindt) that provided four microfluidic channels, which allows for multiplexed, flow-based 
sensor functionalization. A schematic showing the four channel microfluidic gasket is shown in 
Figure 3-2, and each channel covers four or five active microrings. Solutions were introduced to 
the chip at controlled flow rates via negative pressure applied by syringe pumps (11 Plus syringe 
pump, Harvard Apparatus; Holliston, MA). 
 
3.2.3. Surface Functionalization and Capture Agent Attachment 
Sensor chips were cleaned with piranha solution (3:1 H2SO4:30%H2O2) for 1 or 2 
minutes to remove any organic contaminants prior to functionalization, followed by rinsing with 
copious amounts of distilled (DI) water and dried under nitrogen. Microring substrates were then 
loaded into the described custom cell with two-channel microfluidics defined by a Mylar gasket, 
and functionalized by exposure to 1 mg/mL HyNic silane solution in 95% ethanol and 5% DMF 
at 5 μL/min for 30 min, followed by rinsing with 100% ethanol. Then the chip was loaded into a 
four-channel Mylar gasket and a corresponding Teflon cell for multiplxed functionalization. 
A solution of anti-(human thrombin) was buffer exchanged in PBS (pH 7.4) using 
Vivaspin 500 spin columns three times. A 5-fold molar excess of S-4FB solution (0.4 mg/mL in 
DMF) was added to each solution. After 3 hours of incubation, unreacted S-4FB was removed by 
buffer-exchanging into PBS (pH 6.0) using Vivaspin 500 spin columns. A conjugation solution 
was prepared with 50 μg/mL 4FB-modified antibody with 100 mM aniline as a nucleophilic 
catalyst. Thrombin-binding aptamer and a control sequence were also separately buffer 
exchanged in PBS (pH 7.4) as described above to remove any residual ammonium acetate 
present in the sample. A 10-fold molar excess of S-4FB solution was added to each solution and 
incubated overnight in PBS (pH 6.0). After removing unreacted S-4FB using Vivaspin 500 spin 
columns, conjugation solutions were prepared by diluting the DNA solutions to 300 μL (about 
20-30 ng/μL).  
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Figure 3-2. Schematic showing the four channel microfluidics (red) projected on the microchip 
surface. Inlet and outlet portions are shown in a darker red.  
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Each solution of 4FB-modified thrombin-binding aptamer, control sequence, and 
antibody were introduced into each microfluidic channel and flowed over HyNic-modified 
microring resonators at a rate of 5 μL/min for 60 min, followed by rinsing with buffer; PBS (pH 
6.0) for DNA sequences and PBS (pH 6.0) containing 100 mM aniline for antibody.  Aniline was 
added to the antibody conjugation solution as a nucleophilic catalyst that improves the amount of 
covalently bound antibody.
48
 To further remove any residual antibody, antibody channel was 
exposed to a low pH glycine buffer (pH = 2.2) for 2 min. After capture agent immobilization, the 
four-channel Mylar gasket and the Teflon cell were switched back to two-channel microfluidics. 
The remaining unmodified microrings and the antibody immobilized microring surfaces, which 
were in the same microfluidic channel at this point, were blocked with 2 % (w/v) BSA in PBS 
(pH 7.4) at least for two hours in order to reduce non-specific protein adsorption in subsequent 
antigen detection experiments. 
 
3.2.4. Antigen Detection 
A solution of human α-thrombin was buffer exchanged to PBS (pH 7.4) using Vivaspin 
500 spin columns. Working solutions containing 500 pM, 2 nM, 5 nM, and 10 nMof human α-
thrombin in Tween-PBS were prepared by successive dilution of a 1 μM stock solution in PBS 
(pH 7.4). These solutions were then flowed over the functionalized sensor chip at 30 μL/min for 
10 min as antigen association was monitored, followed by a Tween-PBS rinse for 20 min to 
observe antigen dissociation. To disrupt the remaining antigen-capture agent interactions and 
regenerate the sensor surface, glycine buffer was introduced to the antibody channel for two 
minutes and 0.1 mg/ml proteinase K solution in Tris buffer was flowed over the aptamer 
immobilized microrings for an hour. A solution of elastase was prepared in the same way as 
human α-thrombin. A Single-blind solution having unknown human α-thrombin concentration 
was generated, by Mr. Adam L. Washburn, who was otherwise not involved in this study, by 
diluting 1 μM stock solution with Tween-PBS.   
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3.2.5. Data Processing 
Sensor microring data was corrected for any non-specific binding and a drift related to 
thermal and instrumental fluctuations by referencing to control microrings, which were either 
modified with random DNA control sequence or blocked with BSA. Offline, residual slope as 
well as offset of the baseline were corrected, and data aligned temporally at the point when 
antibody or antigen was introduced.  
To obtain the values of association rate constant (ka) and the dissociation rate constant 
(kd), the association curves were fitted to a 1:1 binding model: 
49, 50
 
                                                          
         
      
                                                    
where pm(t) is the relative peak shift,  pmmax is the maximum signal obtained when all surface 
binding sites are occupied, and C is the protein solution concentration. Using the Langmuir 
adsorption isotherm, Equation 1 can be simplified to: 
                                                                   
                                                       
where θ is the fraction of total surface coverage and: 
                                                                                                                                                                         
Values of ka and kd are determined from the slope and y-intercept by plotting γ as a function of C 
and a binding affinity constant, KD, is defined as the ratio of the rate constants (KD= ka/kd). The kd 
values were also determined independently from the dissociation curves by fitting to a simple 
exponential decay function: 
                                                                           
                                                                                                       
where       is the maximum peak shift at each concentration.  
The derivative of Equation 3-2, evaluated at t = 0, gives initial slopes of the association curves. 
Initial slope values determined from the fitting parameters were plotted as a function of 
concentration to construct a calibration curve and to evaluate unknown sample concentration. All 
data fitting was performed using the OriginPro 8 software package (OriginLab Corporation; 
Northampton, MA).    
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 3.3. Results and Discussion 
   
  For an evaluation of different capture agents, capture agents should be simultaneously 
immobilized on the same sensor surface. Otherwise, chip-to-chip variation or slight 
difference in immobilization conditions such as temperature or humidity can lead to 
inconsistent results. Therefore, functionalizing a chip in a multiplxed manner was essential 
for this study, and the described 4 channel microfluidic design was utilized for this purpose. 
Previously, a spotting technique was tried out to individually functionalize microrings on a 
sensor chip since printing methods have several advantages, such as the use of small sample 
quantity and multiplexing.
51, 52
 One of the contact printing techniques, Nano eNabler 
(BioForce, Ames, IA)
53
 is equipped with cantilever-based microfluidic device and was used 
for multiplexed functionalization and the deposition of small volume of sample was 
performed without much difficulty. However, after the capture agent immobilization, we 
found that overall antigen binding response was lower compared to the result obtained after 
fluidic-based immobilization, which indicates non-optimal immobilization of the capture 
agents. Furthermore, the results were not consistent; especially monoclonal antibodies tended 
to show worse performance (data not shown).The implementation of contact-based printing 
methods onto the microring sensor array is feasible, but appears to require further 
optimization. 
 In contrast, the flow-based microfluidic functionalization strategy was reproducible and 
the capture agents‘ loading level is sufficient for robust kinetic measurements. A typical result of 
simultaneous sensor functionalization is shown in Figure 3-3. Four components used in 
functionalization were thrombin-binding aptamer, random DNA sequence, anti-(human thrombin) 
antibody, and bovine serum albumin (BSA). The random DNA sequence and BSA served as on-
chip controls for thrombin-binding aptamer and antibody, respectively, to correct the effects of 
non-specific adsorption and bulk solution refractive index changes. Except BSA, the two active 
capture agents and one control sequence were 4FB modified for simultaneous functionalization 
through the previously descirbed hydrazone bond formation reaction, and after that all four 
channels were blocked with BSA to reduce non-specific adsoption.  As shown in Figure 3-3, 
larger resonance shifts were observed in the antibody channel (~470 pm) compared to the other   
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Figure 3-3. Real-time shifts in resonance wavelength from 9 microrings (3 each) upon covalent 
immobilization of 4FB-modified capture agents; anti-thrombin antibody (green) and thrombin-
binding aptamer (red), and DNA control sequence (black). 
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two oligonucleotide channels (~120 pm) largely  due to the big difference in molecular 
weight (150 kDa vs.  10 kDa). 
  After sensor chip functionalization, the aptamer and antibody were each covalently 
attached to three microring array elements, and the sensor chip was tested to indentify 
appropriate right regeneration methods. To ensure complete removal of bound thrombin, the 
sensor surface needs to be chemically regenerated in between exposure to solutions of 
different concentration. Antibody-antigen complexes are dissociated using glycine buffer 
(pH = 2.2), while aptamer surfaces are regenerated using proteinase K. It has been reported 
that 2 M NaCl can regenerate thrombin-binding aptamer based sensor surface, but we 
observed incomplete regeneration under these conditions. However, as shown in Figure 3-4, 
proteinase K, which enzymatically consumes any bound thrombin, leaves the covalently 
bound DNA aptamer available for subsequent binding experiments.  
  Once regeneration conditions were optimized, various concentrations of human α-
thrombin, solutions ranging from 500 pM to 10 nM, were flowed over the entire sensor array 
and the shifts in resonance wavelength were monitored as a function of time as thrombin 
associated and dissociated from each of the capture agent-modified sensor surfaces. Figure 3-
5. shows real-time resonance wavelength shifts from representative microrings 
functionalized with the anti-thrombin antibody (a) and thrombin-binding aptamer (b). Both 
capture agents display expected concentration-dependent responses where larger shifts in 
resonance wavelength are elicited when thrombin solutions having higher concentrations are 
flowed across the sensor array. Upon switching the solution to buffer (no thrombin), the 
bound antigen dissociates and the resonance wavelength returns towards the original baseline 
value.  
 In order to verify the selectivity of capture agents, solutions containing elastase, a serine 
protease with a molecular weight and an isoelectric point similar to that of thrombin, were 
flowed across the sensor surface (Figure 3-6). No specific binding response was detected over a 
relevant concentration range on either the antibody or aptamer-coated microrings. However, at a 
higher concentration of elastase (50 nM) a negative shift in the resonance wavelength was 
observed for microrings functionalized with the antibody, an observation that we attribute to the 
enzymatic degradation of the protein-based capture agent due to the proteolytic activity of 
elastase. Notably, the negative shift was not observed for the DNA-based aptamer capture agent, 
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Figure 3-4. Eight consecutive surface regeneration of thrombin-aptamer functionalized surfaces. 
Every run was following the sequential flow of following solutions; Tween-PBS (a few minutes),  
50 nM thrombin incubation (10 min), Tween-PBS (5 min), Proteinase K (0.1 mg/ml) in Tris 
buffer (50 mM Tris-HCl, 100 mM KCl, and 5 mM CaCl2 at pH 7.4) (30-60 min), and Tween-
PBS (at least 10 min). 
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Figure 3-5. Time-resolved detection of human thrombin using microrings modified with (a) an 
antibody and (b) an aptamer. Thrombin solutions were injected t = 6 min and the chamber 
returned to buffer at t = 16 min. Each measurement was made with three independent microrings; 
however, data from only a single ring is presented for clarity. 
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                              (a) 
 
 
 
 
 
 
                              (b) 
 
 
 
 
 
 
 
Figure 3-6. Real-time monitoring of resonance wavelength shifts of (a) antibody functionalized 
microrings (n=6 or 7) upon 10 min exposure to 5 nM and 50 nM (inset) elastase, and (b) 
thrombin-binding aptamer functionalized microrings (n=10) upon 10 min exposure to 50 nM 
elastase.  
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as nucleic acids are not damaged by proteases.  
  The real-time shifts in resonance wavelength accompanying target binding and 
unbinding were used to determine the capture agent evaluative metrics, namely the 
association (ka) and the dissociation rate constants (kd) by assuming a 1:1 binding model.
49, 50, 
54
 Both ka and kd were determined by fitting the association component of the real-time 
binding trace to equation (3-2). The values of ka and kd were determined by plotting γ as a 
function of thrombin concentration as shown in Figure 3-7, and the fitting paramerter are 
shown in Table 3-1. For both the anti-thrombin antibody and thrombin-binding aptamer, the 
plots of  versus concentration nicely followed a linear relation and ka and kd were extracted 
as the slope and intercept of the linear fit, respectively. However, when kd is small, the y-
intercept values determined by the above approach can be inaccurate.
49
 Therefore, the kd 
values were also independently determined by directly fitting the dissociation curves to the 
simple exponential decay function, equation (3-4). Conveniently, both methods of kd 
determination give similar values, which are compiled in Table 3-2 along with values for ka. 
  Consistent with visual inspection of the real-time binding data in Figure 3-5, the 
thrombin-binding aptamer has faster rates of both antigen association and dissociation, when 
compared to the antibody. Using determined values for ka and kd, KD was calculated 
(KD=kd/ka) to be in good agreement with published values for both the antibody
55
 and 
aptamer.
56
 When comparing KD values we determine that the antibody is a higher affinity 
(smaller KD) capture agent, which means that it will give lower limits of detection for most 
sensor applications.  
 Since one application of the microring resonator technology is biomolecular detection, 
we simultaneously investigated the utility of both the antibody and aptamer capture agents for 
the quantitation of thrombin. Previously we have utilized an initial slope-based quantitation 
method
47, 57, 58
 whereby the initial slope of sensor response is plotted versus concentration to give 
a linear calibration curve. This approach has several advantages over equilibrium methods in that 
it offers a shorter time to result and broader linear dynamic range. Applied to the detection of 
thrombin, and using the standard solution data from Figure 3-5, microrings functionalized with 
the antibody and aptamer capture agents were both successful in determining the concentration 
of a blinded thrombin solution, yielding values of 3.0   0.7 nM and 4.2   2.2 nM, respectively, 
for a solution prepared to be 3.0 nM as shown in Figure 3-8. Interestingly, the faster association 
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Figure 3-7. Plot of γ values as a function of thrombin concentration obtained from the 
association curves of microrings modified with (a) an antibody and (b) an aptamer. Error bars 
represent ±1 standard deviation of γ values determined from three independent microrings 
simultaneously measuring at each concentration.   
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Table 3-1. Fitting parameters for exponential fits shown in Figure 3.5. 
 Antibody    Aptamer   
Concnetration         
(pm) 
γ 
(min
-1
) 
Adjusted 
R
2
 
         
(pm) 
γ 
(min
-1
) 
Adjusted 
R
2
 
0.5 nM 10.03966 0.108559 0.97612  8.00231 0.204718 0.96948 
0.5 nM 7.63191 0.108908   7.17794 0.293393  
0.5 nM 7.4482 0.102562   5.25897 0.356789  
        
2 nM 17.41137 0.140481 0.98947  18.6503 0.346242 0.98481 
2 nM 13.28245 0.156478   15.99563 0.392516  
2 nM 15.08133 0.13567   19.266 0.348405  
        
5 nM 22.59784 0.235496 0.99475  30.0087 0.438546 0.99059 
5 nM 20.65596 0.208459   23.89006 0.394851  
5 nM 19.81447 0.228032   22.05732 0.566447  
        
10 nM 25.09331 0.302154 0.98715  31.29988 0.537579 0.97483 
10 nM 19.43686 0.39485   24.85344 0.515815  
10 nM 21.63722 0.404929   24.3762 0.811194  
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Table 3-2. Determined kinetic and equilibrium interaction constants of antibody and aptamer 
capture agents.  
 Antibody Aptamer 
ka (M
-1
s
-1
) 
a 
4.6 (± 0.1)  105 5.8 (± 0.4)   105 
kd (s
-1
) 
a
 1.5 (± 0.01)  10-3 4.7 (± 0.2)  10-3 
KD (M) 
a 
3.3 (± 0.1)  10-9 8.2 (± 0.6)  10-9 
kd (s
-1
) 
b 
1.4 (± 0.3)  10-3 3.5 (± 1.3)  10-3 
 
a: Rate constants determined from the plot of γ vs thrombin concentration 
b: Rate constants determined from fitting the dissociation curves 
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                            (a) 
 
 
 
 
 
 
                          (b) 
 
 
 
 
 
 
 
Figure 3-8. Overlay of the unknown solution on calibration plots for thrombin as determined by 
the initial slope method for microrings functionalized with (a) an anti-thrombin antibody and (b) 
the thrombin-binding aptamer. Error bars represent ± 1standard deviation of initial slope values 
determined from three microrings simultaneously measuring each concentration.  
 
  
0 2 4 6 8 10
0
5
10
15
20
25
y = 0.71x + 0.68
R
2
= 0.99
Concentration (nM)
In
it
ia
l 
S
lo
p
e
 (
p
m
/m
in
)
Unknown: 
 2.5 nM
0 2 4 6 8 10
0
5
10
15
20
25
y = 1.8x + 1.8
R
2
= 0.98
Unknown: 
 3.8 nM
In
it
ia
l 
S
lo
p
e
 (
p
m
/m
in
)
Concentration (nM)
75 
 
rate of the aptamer capture agent gives it a steeper calibration plot, i.e. the initial slope is 
greater for the aptamer, compared to the antibody, for the same concentration. This is 
significant because it means that the aptamer capture agent actually gives a lower limit of 
detection, despite having an affinity that is ―worse‖ than its antibody counterpart.  
 
3.4. Conclusion 
 
  In this chapter, the ability to simultaneously evaluate multiple capture agents against 
the same target antigen using arrays of silicon photonic microring resonators was 
demonstrated. In parallel the evaluative metrics of antibody and aptamer capture agents that 
recognize human thrombin we determined and it is suggested that, despite having a ―worse‖ 
affinity, the aptamer agent can be used to quantitate the target antigen with a lower limit of 
detection using an initial slope-based quantitation method. Importantly, we envision that the 
ability to monitor in parallel the binding kinetics of multiple biomolecular interactions on a 
scalable and cost-effective platform will be of great utility in evaluating protein binding 
agents for a range of biomedical applications. 
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Chapter 4 
 
Multiplexed Evaluation of Anti-Ricin Capture Agents Binding 
Kinetics Using Arrays of Silicon Photonic Microring Resonators 
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4.1. Introduction 
 
Ricin (Ricinus communis agglutinin II ) is a highly toxic protein derived from the castor 
bean plant (Ricinus communis).
1
 Castor beans (Ricinus communis seeds) are used to produce 
castor oil, and the resulting waste pulp contains about 1-5% ricin.
2
 Ricin is a very lethal toxin as 
shown in mouse studies; the lethal dose (LD50) is 1–10 μg/kg when delivered by injection or 
inhalation.
3
 Although the lethal dose by ingestion is approximately three orders of magnitude 
higher, in part due to poor absorption by the intestine, the high lethality and the relative ease of 
extraction makes ricin one of the most threatening toxins. Not surprisingly, ricin is listed as a 
Category B bioterrorism agent.
4
  
Ricin, a member of type 2 ribosome inactivating proteins (RIPs), is composed of an A- 
and a B-chain linked by a single disulfide bond.
5
  The ricin A-chain is 32 kDa and is responsible 
for its enzymatic toxicity. The ricin B-chain is 34 kDa and catalytically inactive, but aids in the 
delivery of the toxin into cells. The B-chain, which is highly glycosylated, binds the toxin to cell 
surface glycoproteins and glycolipids, and mediates the internalization of toxin.
6
  Once ricin 
enters into cells by endocytosis, the toxin undergoes retrograde transport from the Golgi 
apparatus and endoplasmic reticulum (ER).
7-9
 In the ER, ricin is cleaved into its A and B chain 
components by protein disulphide-isomerase and transported into the cytosol with the help of ER 
chaperons and translocators.
10, 11
 The ricin A-chain interacts with the 28S ribosomal RNA 
(rRNA), which is a part of the 60S ribosomal subunit, and catalytically depurinates a single 
adenosine at position 4324 in the GAGA stem-loop region of the RNA, conserved in eukaryotes 
and prokaryotes.
12-14
 This removal of adenine by hydrolysis results in the inhibition of the 
binding of elongation factor 2 (EF-2) to 28S rRNA, which subsequently prevents protein 
synthesis and induces cell death.
15, 16
  
Because of increased concerns over bioterrorism, the need for developing sensitive and 
selective detection methods for ricin has gained interest. Previously described approaches have 
been based on the catalytic activity of ricin on GAGA stem-loops employing HPLC separation 
with fluorescent derivatization
17
, a colorimetric
18
 or  luminescent assay,
19
 DNA beacons,
20
 or 
mass spectrometry.
21
  However, each of these assays detects either released adenines or 
DNA/RNA substrates, as opposed to intact ricin. Therefore, false positives caused by DNases or 
RNases or other toxins in RIP family present in samples can present analytical challenges. 
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Another common detection approach is based upon antibody based immunoassays in different 
formats. These assays include ELISA, immuno PCR,
22
 or sensors modified with 
antibodiesatomic force microscopy (AFM),
23, 24
 nanoparticle-tagging,
25
 SPR.
26
 Ricin has also 
been detected by mass spectrometry in its intact form
27
 and identified after tryptic digestion.
28
 
Even though antibody-based methods are the most commonly used detection methods, there are 
few commercially available monoclonal antibodies against ricin, and widely used polyclonol 
antibodies suffer from poor-specificity.  
As an alternative to conventional monoclonal antibodies, a wide variety of capture agents, 
such as nucleic acid aptamers,
29-31
 single domain antibodies,
32, 33
 multivalent peptide scaffolds,
34-
37
 peptoids,
38
 and molecularly imprinted polymers,
39
 have been  proposed for biodetection. 
Among them, single domain antibodies have gained interest as capture agents for toxins and 
microbes.
40
 Unlike most antibodies,  camelids
32
 and sharks
33
 naturally produce heavy chain 
antibodies that are devoid of light chains (Figure 4-1).  Single domain antibodies refer to the 
recombinantly produced variable domains (VHH) of these heavy chain antibodies. 
40-42
  Using 
phage display technology,
43-45
 single domain antibodies with high affinity and specificity can be 
relatively easily selected.
46
 Since VHH domains are hydrophilic in contrast to VH domains in 
conventional antibodies, which are hydrophobic, single domain antibodies are highly soluble, 
leading to higher expression yields, good thermal stability and the resistance to denaturation.
47
  
Furthermore, since single domain antibodies can be as small as ~15 kDa, they can potentially 
access to hidden antigenic sites more efficiently.
48
 All these properties make single domain 
antibodies suitable for sensing applications as well as therapeutics and diagnostics.   
Recently, Anderson et al. developed single domain antibodies against ricin using phage 
display technology.
41-45
 The phage display library was constructed from mRNAs isolated from 
llama lymphocytes immunized with ricin toxin. They evaluated the kinetic parameters of anti-
ricin single domain antibodies, and selected the ones with high specificity and high affinity. In 
this study, silicon photonic microring resonators were investigated as a multiplexed platform for 
simultaneous evaluation of the kinetics of three different capture agents- two single domain 
antibodies and one conventional antibody against ricin. Preliminary data demonstrating the 
specificity of capture agents, obtained kinetic parameters. 
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Figure 4-1.  Cartoon showing conventional antibodies, heavy chain antibodies, and their cloned 
binding elements. Variable domains have been colored red and blue for the conventional VH and 
VL respectively, and purple for the VHH. Adapted from reference 41(Open access).  
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4.2. Experimental Section 
 
4.2.1. Materials 
3-N-((6-(N'-Isopropylidene-hydrazino))nicotinamide)propyltriethyoxysilane (HyNic 
silane) and succinimidyl 4-formylbenzoate (S-4FB) were purchased from SoluLink (San Diego, 
CA); aniline was obtained from Acros Organics (Geel, Belgium). Ricinus communis agglutinin II 
(ricin, Cat. # L-1090), Ricinus communis agglutinin I (RCA I, Cat. # L-1080 ), goat anti-Ricinus 
communis agglutinin (RCA) I & II  (Cat. # AS-2084), and goat IgG isotype control (Cat. # I-
5000) were purchased from Vector Laboratories Inc. (Burlingame, CA).  Single domain 
antibodies against ricin (clones C8 and B4) were kindly donated by Dr. George P. Anderson at 
Naval Research Laboratory. Their sequences are shown in Figure 4-2.  Zeba spin filter columns 
were purchased from Pierce (Rockford, IL). All other chemicals were obtained from Sigma-
Aldrich (St. Louis, MO) and used as received. 
All buffers were made with purified water (ELGA PURELAB filtration system; Lane 
End, UK), and their pHs were adjusted with 1 M HCl or 1 M NaOH. PBS was reconstituted from 
Dulbecco‘s phosphate buffered saline packets and adjusted to either pH 6.0 or 7.4. Glycine 
buffer consists of 10 mM glycine and 160 mM NaCl adjusted to pH 2.2. A blocking solution 
containing 2 % (w/v) BSA was prepared by dissolving bovine serum albumin in PBS (pH 7.4) 
and degassed under vacuum before being flowed across the sensor surface. Tween-PBS buffer 
was prepared by adding 0.05% (v/v) Tween 20 in PBS (pH 7.4).  
 
4.2.2. Sensor Substrates and Instrumentation 
The description of microring resonator sensor chips and the instrumentation used in this 
study are the same as described previously. 
49, 50
 Sensor chips are loaded into a custom Teflon 
cell with microfluidic channels defined by a Mylar gasket (fabricated by RMS Laser; El Cajon, 
CA), which allow either two or four separate solutions to be directed to different regions of the 
sensor array. Solutions are introduced to the chip at controlled flow rates via negative pressure 
applied by syringe pumps (11 Plus syringe pump, Harvard Apparatus; Holliston, MA). 
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4.2.3. Surface Functionalization and Capture Agent Attachment 
Sensor chips were cleaned with piranha solution (3:1 H2SO4:30%H2O2) for 1-2 minutes 
to remove any organic contaminants prior to functionalization, followed by rinsing with copious 
amounts of distilled (DI) water and dried under nitrogen. Microring substrates were then loaded 
into the described custom cell with two-channel microfluidics defined by a Mylar gasket, and 
functionalized by exposure to 1 mg/mL HyNic silane solution in 95% ethanol and 5% DMF at 5 
μL/min for 30 min, followed by rinsing with 100% ethanol. The chip was then loaded into a 
four-channel Mylar gasket and a corresponding Teflon cell for multiplexed functionalization. 
Solutions of goat anti-RCA I & II and isotype control goat IgG were buffer exchanged 
three times in PBS (pH 7.4) using Vivaspin 500 spin columns. A 5-fold molar excess of S-4FB 
solution (1 mg/mL in DMF) was then added to each solution to install aryl aldehyde reactive 
groups. After two hours of incubation, unreacted S-4FB was removed by buffer-exchanging into 
PBS (pH 6.0) using Vivaspin 500 spin columns. Conjugation solutions were prepared with 50 
μg/mL 4FB-modified antibody with 100 mM aniline as a nucleophilic catalyst. Two kinds of 
single domain antibodies, C8 and B4, were also separately buffer exchanged in PBS (pH 7.4) 
using Zeba spin filter column. Except for the buffer exchange processes, other conditions were 
identical to those described above. 
Each solution of 4FB-modified anti-RCA I & II, isotype control goat IgG, C8 and B4 
were introduced into each microfluidic channel and flowed over HyNic-modified microring 
resonators at a rate of 5 μL/min for 30 min, followed by rinsing with buffer, PBS (pH 6.0) 
containing 100 mM aniline. Aniline was added to the antibody conjugation solution as a 
nucleophilic catalyst that accelerates the rate of hydrazone bond formation between the aryl 
aldehyde group installed on the proteins and the hydrazine group on the surface.
51
 To further 
remove any residual antibody after buffer rinse, channels were exposed to a low pH glycine 
buffer (pH = 2.2) for 10 min. After capture agent immobilization, antibody immobilized 
microring surfaces were blocked with 2 % (w/v) BSA in PBS (pH 7.4) for at least two hours to 
reduce non-specific protein adsorption in subsequent antigen detection experiments. 
 
4.2.4. Antigen Detection 
A solution of RCA I was buffer exchanged to PBS (pH 7.4) using Vivaspin 500 spin 
columns. Working solutions containing 300 pM, 1 nM, 3 nM, 10 nM and 30 nM of RCA I in 
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Tween-PBS were prepared by successive dilution of a 1 μM stock solution in PBS (pH 7.4). In 
the case of ricin, desalting step was excluded to reduce the exposure of ricin solution to air. Since 
ricin comes in 10 mM phosphate buffer with 0.15 M NaCl and 0.08% sodium azide, the bulk 
refractive index of sodium azide was monitored prior to ricin detection. The same concentrations 
of working solutions were prepared in Tween-PBS. These solutions were then flowed over the 
functionalized sensor chip at 30 μL/min for 10 min as antigen association was monitored, 
followed by a Tween-PBS rinse for 20 min to observe antigen dissociation. To disrupt the 
remaining antigen-capture agent interactions and regenerate the sensor surface, glycine buffer 
was introduced to the antibody channel for 10 minutes, followed by a return to the running buffer 
to re-establish the sensor baseline.  
 
4.2.5. Data Processing 
Sensor microring data was corrected for drift related to thermal and instrumental 
fluctuations by referencing to control microrings, which were on-chip, but occluded by the 
perfluoropolymer cladding layer and thereby not directly exposed to solutions. To obtain the 
values of association rate constant (ka) and the dissociation rate constant (kd), the association 
curves were fitted to a 1:1 binding model: 
52, 53
                                            
                                           
         
      
                                                            
where pm(t) is the relative peak shift in picometers,  pmmax is the maximum signal obtained 
when all surface binding sites are occupied, and C is the protein solution concentration. Using 
the Langmuir adsorption isotherm, Equation 4-1 can be simplified to:                                                  
                                                                 
                                                          
where θ is the fraction of total surface coverage and:                                                                    
                                                                                                                                                
                                                        
Values of ka and kd are determined from the slope and y-intercept by plotting γ as a function of C 
and the binding affinity constant, KD, defined as the ratio of the rate constants (KD= ka/kd). The kd 
values were also determined independently from the dissociation curves by fitting to a simple 
exponential decay function:                                                          
                                                                        
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where       is the maximum peak shift at each concentration. The derivative of Equation 4-2, 
evaluated at t = 0, gives initial slopes of the association curves. Initial slope values determined 
from the fitting parameters were plotted as a function of concentration to construct a calibration 
curve and to evaluate unknown sample concentration. All data fitting was performed using the 
OriginPro 8 software package (OriginLab Corporation; Northampton, MA).    
4.3. Results and Discussion 
 
  Following functionalization with HyNic silane, aryl aldehyde presenting three 
different capture agents against ricin and an isotype contol goat IgG were coupled to the 
surface by aniline-catalyzed hydrazone bond formation. In this study, isotype contol goat IgG 
was chosen as an on-chip control for non-specific adsorption and bulk refractive index 
changes. As shown in Figure 4-3, 30 min incubation in antibody solution followed by glycine 
rinse resulted in about 380 pm in peak shift for C8, 320 pm for B4, 550 pm for isotype contol 
goat IgG, and 480 pm for anti-RCA. Both goat IgG and anti-RCA immobilization levels are 
similar to what we normally observe for conventional antibodies with 150 kDa molecular 
weight. Single domain antibodies are, however, 10 times smaller than conventional 
antibodies in molecular weight (14 kDa). Considering that 300-400 pm peak shift seems big, 
single domain antibodies can however be packed more densely on the microring surface 
because of their smaller size. The areal mass density that the instrument is sensitive to 
therfore do not deviate from that for conventional antibodies. One thing to note here is that 
the glycine rinsing step was longer (10 min) than  what we normally use (2 min). We found 
that anti-RCA tends foul to the sensor surface more than other antibodies, such that a short 
glycine rinse was not enough to remove all non-specifically bound antibodies. This translates 
to decrease in antigen binding response for the same concentration in a first few runs (data 
not shown) as non-covalently bound antibodies continued to come off of the surface. The 
noticably large decrease in peak shift after glycine buffer treatment confirms the higher non-
specific binding tendency of anti-RCA.    
 After sensor chip functionalization, various concentrations of ricne solutions ranging 
from 300 pM to 30 nM, were then flowed over the functionalized sensor array and the shifts in 
resonance wavelength were monitored as a function of time as antigen associated and  
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Figure 4-3.  Real-time shifts in resonance wavelength upon covalent immobilization of 4FB-
modified capture agents; single domain antibody C8 (pink), B4 (blue), anti-RCA (red) and 
isotype control goat IgG (black). 
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dissociated from each of the capture agent-modified sensor surfaces. Figure 4-4 shows real-
time resonance wavelength shifts from all microrings functionalized with C8 (pink), B4 
(blue), anti-RCA (red), and goat IgG (black). All capture agents display expected 
concentration-dependent responses, where larger shifts in resonance wavelength are elicited 
when ricin solutions having higher concentrations are flowed across the sensor array. After 
10 min of ricin incubation, the solution was switched back to buffer so that the dissociation 
of bound antigen can be monitored. At all concentrations, anti-RCA‘s reponse to ricin is 
higher than the other two single domain antibodies‘, indicating  that anti-RCA is the most 
sensitive to ricin among these three capture agents. ―On‖-rates are faster, and the dissociation 
curves almost flat, indicating strong affinity toward ricin. Among single domain antibodies, 
C8 looks almost comparable to anti-RCA, slightly less sensitive, and the dissociation was 
almost negligible. B4 showed almost similar ―on‖-rates at the beginning of ricin injection but 
the peak shifts saturated at low relative shifts compared to others. Also dissociation of ricin 
was faster than others.  
  Before evaluating kinetic constants quantitatively, RCA I solutions in the same 
concentration range were flowed over the chip to verify the specificity of capture agents. 
RCA I is about twice larger than ricin in molecular weight and it is much less toxic than 
ricin. As shown in Figure 4-5, RCA I binds to anti-RCA almost equally or more strongly 
while C8 and B4 show no significant response. Thus, one would not be able to distinguish 
RCA I and ricin using this anti-RCA antibody. Another thing to notice is the large response 
of goat IgG to RCA I. The goat isotype control IgG was chosen to use it as an on-chip 
control, but it seems that goat IgG actually interacts with RCA I specifically to some extent 
as it is confirmed by the much larger decrease in peak shift in the dissociatioin phase than 
other capture agents. While better controls must be utilized in the future, for this particular 
experiment, we decided to evaluate the kinetics of ricin/single domain antibody binding 
assuming that there‘s no significant non-specific interaction involved in the measurements 
shown in Figure 4-4.       
 The real-time shifts in resonance wavelength accompanying target binding and unbinding 
were used to determine the capture agents‘ kinetic parameters, the association (ka) and the 
dissociation rate constants (kd) by assuming a 1:1 binding model.
52-54
 Figure 4-6 shows the 
overlay of three (for C8) or four (for B4) microrings‘ binding curves at all concentrations 
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(a) 0.3 nM 
 
 
 
 
 
(b) 1 nM 
 
 
 
 
 
(c) 3 nM 
 
 
 
 
 
(d) 10 nM 
 
 
 
 
 
(e) 30 nM 
 
 
 
 
Figure 4-4. Time-resolved detection of various concentrations of ricin using microrings 
modified with single domain antibody C8 (pink), B4 (blue), anti-RCA (red), and goat IgG 
(black); reference rings are shown in green. Ricin solutions were injected at t = 6 min and the 
chamber returned to buffer at t = 16 min. 
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(a) 0.3 nM 
 
 
 
 
 
 
 
 
(b) 1 nM 
 
 
 
 
 
(c) 3 nM 
 
 
 
 
 
(d) 10 nM 
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Figure 4-5. Time-resolved detection of various concentrations of RCA I using microrings 
modified with single domain antibody C8 (pink), B4 (blue), anti-RCA (red), and goat IgG 
(black); reference rings are shown in green. Ricin solutions were injected at t = 6 min and the 
chamber returned to buffer at t = 16 min. 
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Figure 4-6. Time-resolved detection of ricin using microrings modified with (a) C8 and (b) B4. 
Ricin solutions were injected at t = 6 min and the chamber returned to buffer at t = 16 min. Fit 
curves are also shown overlapped. 
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along with the fit curves. After fitting the association curves, both ka and kd were determined 
by plotting γ as a function of ricin concentration as described in equation (3). The resulting 
calibration plots are shown in Figure 4-7. The determined kinetic constants and the 
calculated equilibrium constant KD (KD=kd/ka) are summarized in Table 4.1 in the left two 
columns. Because the y-intercept values determined by the above approach can be inaccurate 
when kd is small,
52
 kd values were also independently determined by directly fitting the 
dissociation curves to the simple exponential decay function, equation (4).  Both methods of 
kd determination give similar values for B4, but C8 dissociation curves were not properly 
fitted to an exponential decay function due to a slight upward drift in the dissociation phase 
even after the reference correction. Based on this method of determining kinetic parameters 
(i.e., plotting γ vs. concentration), both single domain antibodies show similar affinity (e.g.  
KD) to ricin. B4‘s association rate constant is a little bit higher than C8, but the dissociation 
rate constant is larger too. Literature values are also shown in Table 4.1. Reported 
association constants of both C8 and B4 are one order larger than our measurement, and the 
dissociation constant of C8 is one order smaller than our measurement. The difference in 
values can be attributed to the fact that we didn‘t have proper control in this study, and other 
differences in experimental conditions such as surface immobilization levels, flow 
conditions, microfluidic geometries, etc. In particular, C8 dissociation curves have to be 
fitted to exponential decay function to get more precise value since the bound ricin comes off 
really slowly, meaning very small kd values. 
   
4.4. Conclusions and Future Work 
 
In conclusion, we have shown some preliminary data to demonstrate the ability to 
simultaneously evaluate multiple capture agents against the toxic ricin protein using arrays of 
silicon photonic microring resonators. Two single domain antibodies demonstrated in this study, 
C8 and B4, showed high specificity toward ricin compared to a conventional antibody. We 
determined in parallel the evaluative metrics of antibody and single domain antibodies, but 
optimization is still needed to obtain more precise kinetic values of these capture agents.  Once 
the control surface is properly chosen, e.g.,a BSA blocked surface, then another similar 
experiment can be performed and kinetic constants simultaneously reevaluated for all capture 
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Figure 4-7. Plot of γ values as a function of thrombin concentration obtained from the 
association curves of microrings modified with (a) C8 and (b) B4. Error bars represent ±1 
standard deviation of γ values determined from three (for C8) or four (for B4) independent 
microrings simultaneously measuring at each concentration.   
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Table 4-1. Determined kinetic and equilibrium interaction constants of antibody and aptamer 
capture agents.  
 C8 B4 C8
c
 B4
 c
 
ka (M
-1
s
-1
) 
a 
1.3 (± 0.2)  105    1.7 (± 0.3)   105 2  106   3  106   
kd (s
-1
) 
a
 9.5 (± 2.8)  10-4 1.5 (± 0.4)  10-3 1  10-5   2  10-3   
KD (M) 
a 
7.4 (± 2.4)  10-9 8.8 (± 2.5)  10-9 8  10-12   9  10-10   
kd (s
-1
) 
b 
N.A. 1.4 (± 0.8)  10-3   
 
a: Rate constants determined from the plot of γ vs thrombin concentration. 
b: Rate constants determined from fitting the dissociation curves. 
c: Literature values obtained from SPR measurement. 
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agents. In the long run, the multiplexing capability of silicon photonic microring resonators 
can be improved-currently it is mainly limited by microfluidic configurations or spotting 
methods-and more than three capture agents can be screened at the same time so that the very 
same chip can be utilized for the simultaneous detection of various toxins.  
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Chapter 5 
 
Using Nanostructuring to Control the Wetting Properties of a 
Perfluoropolymer for Applications in Creating Non-fouling Surfaces 
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5.1. Introduction  
The performance of biological devices can degrade over time due to biomolecules non-
specifically adsorb onto their surfaces. 
1-4
 Proteins are especially notorious for non-specific 
adsorption, and they can produce high background noise and “false positives” in protein 
microarrays and other sensor-based systems. Thus, researchers have invested significant effort in 
the development of non-fouling surface derivatization strategies. For example, a self-assembled 
monolayer of hydrophilic poly(ethylene glycol) (PEG) has been shown to be an efficient foul-
resistant interface.
3, 5, 6
 Several studies have shown that entropically-driven polymer steric 
repulsion, hydration of PEG chains, and polymer chain mobility are the key factors in increasing 
the foul resistancy of PEG. Several experimental factors, such as PEG length and graft density, 
play an important role in improving non-fouling properties.
6, 7
 The polymer brush is another 
promising non-fouling surface modifier, which is an assembly of polymer chains attached to a 
surface by one end; it has been successfully applied in diagnostics and cell culture.
4, 8
 
9
 
Many factors contribute to the protein adsorption process itself including surface 
roughness, surface energy, charge, as well as the properties of the protein itself.
4
  In general, 
surface hydrophobicity is thought to play a major role in biofouling, as proteins tend to denature 
on hydrophobic surfaces, revealing buried hydrophobic domains that are normally hidden from 
solution by the protein’s secondary and tertiary structure. However, it has been recently shown 
that superhydrophobic surfaces, those with a contact angle higher than 150°, can reduce the 
amount of protein adsorption on the surface.
3, 10, 11
 Most superhydrophobic surfaces mimic 
natural structures, such as the lotus leaf with hierarchical topographical features, and this general 
structural motif has been extensively studied to develop materials applicable to microfluidics, 
adjustable lenses, and self-cleaning surfaces.
12-16
 A large number of fabrication methods have 
been developed to create micro- and/or nanostructures on surfaces and to increase the surface 
roughness, including photolithography,
14 
the Langmuir-Blodgett technique,
17
 growing silicon 
nanowire,
18
 laser etching,
19
 electrohydrodynamics,
20
 and plasma etching processes.
19, 21-25 
(Figure 
5-1). 
The influence of roughness on the contact angles of surfaces has been described by the 
Wenzel and Cassie-Baxter models.
26-28
 The Wenzel theory (Figure 5-2a) assumes that a surface  
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Figure 5-1. Natural and synthetic structures showing self-cleaning abilities. (A) an SEM image 
of natural gecko setae. (B) The surface of a lotus leaf with hierarchical roughness.16 (C) The 
hairy structure of lady’s mantle leaf.17 (D-E) SEM images of synthetic setae made of 
micropatterned carbon nanotube bundles of varying size. (F) A higher magnification SEM image 
of synthetic setae showing thousands of vertically aligned carbon nanotubes that act as spatulas. 
Adapted from reference 13. 
  
107 
 
 
 
Figure 5-2. Schematic illustrations of a liquid droplet at the Wenzel state (a) and the Cassie-
Baxter state (b); the corresponding real images of water droplets (c) and (d). Adapted from 
reference 28. 
  
(a) (b) 
(c) (d) 
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is completely wetted by a droplet, and it defines the contact angle of a droplet on a rough surface 
(θr) as  
                                                    cos θr = r cos θs                                                                                     (5-1) 
where r is the roughness factor (the ratio of the actual surface to its geometric surface) and θs is 
the contact angle of water on a smooth surface. Alternatively the Cassie-Baxter theory describes 
the droplet as sitting on top of the peaks of a rough surface (Figure 5-2b), capturing air 
underneath. In this model, the contact angle is defined as  
                                         cos θr = f cos θs  + (1- f )cos θair                                             (5-2) 
where f is the fraction of solid surface area and θair is the contact angle of air.  
Another important concept in characterizing the wetting properties of surfaces is contact 
angle hysteresis (CAH), which is defined as the difference between the advancing and receding 
contact angles of a droplet. A few publications have reported that CAH plays an important role 
in anti-fouling,
29 
but much remains to be elucidated in this area. 
This research focused on the contact angles and CAH of plasma-processed 
perfluoropolymer CYTOP surfaces. It is well known that plasma etching can increase the surface 
roughness of a wide range of materials and change the elementary composition of surfaces, 
thereby tuning the wettability of surfaces.
21-25
 CYTOP is a cyclized, transparent optical polymer 
obtained by copolymerization of perfluoro (alkenyl vinyl ethers), which is easily spun onto 
surfaces with good adhesion. CYTOP is stable in elevated temperatures up to 108°C and most 
chemical exposures, and repels both water and oil. It has been previously used for optical 
waveguide claddings, chemical-resistant protective coatings, and anti-reflective coatings.
30
 Since 
silicon photonic optical resonator chips are covered with CYTOP as a cladding layer, the wetting 
properties were investigated as well as the effects of plasma processing on those wetting 
properties as it pertains to a resistance to biofouling. Different plasma etching conditions were 
used to induce roughness on CYTOP surfaces, and the static contact angle and CAH on those 
surfaces were analyzed. The topography of treated surfaces was examined by AFM to see if there 
was any correlation between surface roughness and contact angle changes. Then a simple 
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microfluidic channel was made to test the protein adsorption properties of different plasma-
processed surfaces.  
 
5.2. Experimental Section 
 
5.2.1. Materials  
Silicon wafers were purchased from Silicon Inc. (Boise, ID). CYTOP (CTX-890A) was 
purchased from Bellex International Co. (Wilmington, DE). Poly(dimethylsiloxane) (PDMS) 
(Sylgard® 184) was purchased from Dow Corning Co. (Midland, MI). Alexa Fluor 647®-
labeled bovine serum albumin (BSA) was purchased from Invitrogen Co. (A34785, Carlsbad, 
CA).  All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO) and used as 
received without further purification. All buffers were made with purified water (ELGA 
PURELAB filtration system; Lane End, UK), and their pHs were adjusted using 1 M HCl or 1 M 
NaOH.  
 
5.2.2. CYTOP-Covered Substrate Preparation and Reactive Ion Etching (RIE) Processes  
Silicon (100) wafers were manually cut into square pieces (1 inch by 1 inch), cleaned 
with piranha solution (3:1 H2SO4:30%H2O2) for 3 minutes to remove any organic contaminants, 
rinsed with copious amounts of deionized (DI) water, and dried under nitrogen. Clean substrates 
were spin-coated with the amorphous perfluoropolymer, CYTOP. The spin acceleration was set 
at 100 rpm/s and the spin speed was maintained at 500 rpm for 5 seconds, then the spin 
acceleration, spin speed, and spin time were increased to 500 rpm/s, 2000 rpm, and 30 seconds, 
respectively. After spinning, substrates were baked on a hot plate (100 ºC) for 90 seconds to 
remove residual solvent and other volatile components by evaporation, then cured in an oven at 
200 ºC for an hour. After curing, reactive ion etching (RIE) (Unaxis/Plasma-Therma) treatments 
were performed with SF6 and O2. SF6 was used in order to increase the amount of C-F bonding 
on the surface so the surface energy would decrease.
31
 The plasma treatment time varied from 10 
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to 270 s. The flow rate of the gas was 20 sccm for O2 and 40 sccm for SF6; the input power was 
either 100 W or 200 W with a base pressure of 20 mTorr.  
 
5.2.3. Surface Characterization: Contact Angle Measurements and Atomic Force 
Microscopy (AFM) 
5.2.3.1.Contact Angle Measurements 
Static contact angles were measured using 20 µL drops of water and a digital contact 
angle goniometer (Model 120-F0, Ramé-Hart, Inc., Netccong, NJ).  
Advancing and receding contact angle measurements were performed with a home-built 
CAH setup. As shown in Figure 5-3, the setup is composed of three parts (from left to right): a 
substrate rotational mount, an optical lens, and an imaging device. A sample substrate was 
placed on a flat, square metal plate (blue), which was mounted perpendicular to a high precision 
rotation mount (PR01, Thorlabs, gray). A light bulb was placed between the rotational mount 
and the sample substrate (green), about 3 cm from the sample. The water droplet was 
photographed with a digital camera (Canon, S3-IS 6MP), and its movement was recorded at a 
rate of 30 frames per second with a digital camera while the surface was tilted.   
Measurements were carried out in air at room temperature. A 20 μL water droplet was 
deposited on the sample substrate using a syringe (Hamilton. Co., Reno, NV ). To make a rough 
measurement of the tilt angle, the rotation mount was tilted from the horizontal at a rotation rate 
of about two degrees per second until the drop started to slide off of the surface. This angle was 
taken as the rough tilt angle. A second measurement was done at a relatively slow rotation rate 
starting from an angle near the ‘rough tilt angle.’ A video was recorded for about 10 seconds, and 
the angle where the drop started to slide off the surface was determined to be the precise tilt 
angle. The video was then analyzed frame by frame to choose the frame where the three-phase 
(air-water-solid) line started moving. Using the DROPimage CA (version 2.0.05) the tangent line 
was determined both at the front edge and at the rear edge of the drop. Finally, the advancing 
contact angle was determined as the angle between the intersection of the tangent line of the 
front edge and the baseline of the substrate; the receding contact angle was measured in the same  
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Figure 5-3. A schematic showing the home-built CAH measurement setup. From left to right: 
sample substrate holder attached to a high-precision rotation mount, optical lens, and a digital 
camera.   
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way at the rear edge of the drop.  For contact angle measurements, four to eight drops of water 
were obtained for each type of sample, and the average values of contact angles are reported.  
 
5.2.3.2. Atomic Force Microscopy (AFM)  
The topography of the samples was characterized by atomic force microscopy (AFM) 
using a Multimode NanoScope IIIa (Digital Instrument, Woodbury, NY) controlled by 
Nanoscope v5.30r3.sr3 software. Sample surfaces were scanned in tapping mode with a silicon 
probe tip (Innovative Solutions Bulgaria Ltd., Bulgaria). The radius and force constant of the tip 
were < 10 nm and 40 N/m, respectively. The sample scan rate was 0.5003 Hz and the scan size 
was either 1μm or 5 μm. The rms (root mean square) roughness and roughness factor were 
analyzed with the software’s “Roughness Analysis” function.  
 
5.2.4. Protein Adsorption Experiments and Fluorescence Imaging  
A fluidic device was fabricated from poly(dimethylsiloxane) (PDMS). The two-part 
liquid components of Sylgard 184, Part A (polymer base) and Part B (curing agent), were mixed 
in a 10:1 ratio by weight and poured onto a master fabricated using photolithography. After 
degassing the cast (but not cured) PDMS for 30-60 minutes under vacuum, the polymer was 
cured either at room temperature overnight or at 80 °C for an hour in an oven. After curing, the 
PDMS mold was peeled off from the master and cut into the desired size. There were five linear 
channels in the mold. They were each 100 μm wide, 40-50 μm high, and 15 mm long. Holes for 
an inlet and an outlet were punched into the mold with a needle and a pin from a tygon tube 
connected to a solution was inserted into the inlet and another pin from a tygon tube connected to 
a syringe was inserted into the outlet. After sealing the PDMS mold and substrates using clamps, 
Alexa Fluor 647-labeled BSA (10 μg/ml) was drawn through microfluidics across the substrates 
at a flow rate of 30 μL/min for 3 minutes via negative pressure applied by a syringe pump (11 
Plus syringe pump, Harvard Apparatus; Holliston, MA). Before and after the BSA incubation, 
the microfluidic channel was rinsed with PBS.  
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5.3. Results and Discussion 
To characterize the wettability of these plasma-processed surfaces, their static contact 
angles and contact angle hysteresis (CAH) were measured. For the CAH determinations, the 
substrate was tilted from the horizontal position and the advancing (or receding) contact angle 
was measured at the leading (or rear) edge of the droplet at the moment when the contact line 
started to move. The results are shown in Figure 5-4. The static contact angle (Figure 5-4a) of 
CYTOP surfaces increased for the first 30 seconds of RIE for all three etching conditions. After 
10 seconds of etching, O2-etching resulted in substrates with higher contact angles than those of 
neat CYTOP surfaces. However, SF6 plasma produced contact angles lower than those of neat 
CYTOP. As the surface roughened, its contact angle increased quite rapidly during the first 30 
seconds of RIE. However, after 30 seconds the static contact angle started to decrease for both 
O2-etching (100W, yellow) and SF6-etching (200W, blue). On the other hand, the contact angle 
of SF6-etched (100 W, blue) CYTOP increased for the first 150 seconds of RIE and then 
decreased. Interestingly, between 90 seconds and 150 seconds of etching, contact angles higher 
than 150° were obtained, which means that a superhydrophobic surface was produced. In Figure 
5-4b, the measured CAHs of the same surfaces are shown. In the case of O2 etching, the water 
droplet adhered to the surface at all times: even when the substrate was rotated to 90° and CAHs 
were not measurable. In the case of SF6 etching, after either a short (<20 s for 200W or <60s for 
100 W) or a long (>90 s for 200 W) etching, the water droplet did not roll off the surface as well. 
However, at an intermediate etching time advancing and receding contact angles were 
measurable and the calculated CAHs ranged from 20° to 50°. These values are higher than the 
CAH of neat CYTOP, which is 10.6°.  It seems that the RIE process introduces heterogeneity 
into the surface and this increases the CAH. 
For morphological characterization, atomic force microscopy (AFM) images were 
obtained in tapping mode, and images of SF6 plasma (100 W) treated CYTOP surfaces are shown 
in Figure 5-5. The analyzed rms roughness and roughness factor, along with the measured and 
calculated contact angles are summarized in Table 5-1. It is clear that the surface roughness 
increases with longer etching times. As listed in Table 5-1, the calculated rms roughness and 
roughness factor increase as the etching time increases. To correlate the relationship between the 
roughness of the surface and the measured contact angle, the Wenzel model was chosen and the  
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Figure 5-4. (a) Static contact angle and (b) contact angle hysteresis of neat CYTOP (black) and 
plasma-etched CYTOP with a feed gas of SF6 at 100W (red), O2 at 100W (yellow), or SF6 at 
200W (blue). 
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Figure 5-5. AFM images of SF6 plasma (100 W) processed CYTOP surfaces at different etching 
times: (a) 10 s, (b) 20 s, (c) 30 s, (d) 60 s, (e) 90 s, (f) 120 s, (g) 150 s, and (h) 180 s. 
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Table 5-1. The rms roughness, roughness factor (r, the ratio of the actual surface to its geometric 
surface) and the calculated contact angle (r cos θs,  θs =113.4°) of different plasma processed 
surfaces.  
 
 SF6 (100W)  O2 (100W) SF6 (200W) 
etchin
g  
time  
(s) 
rms  
roughn
ess 
(nm) 
roughn
ess  
factor, r 
measur
ed 
contact 
angle 
calculat
ed  
contact 
angle 
rms  
roughn
ess 
(nm) 
roughn
ess 
 factor, 
r 
measur
ed 
contact 
angle 
calculat
ed 
contact 
angle 
rms  
roughn
ess 
(nm) 
roughn
ess  
factor, r 
measur
ed 
contact 
angle 
calculat
ed 
contact 
angle 
10 0.988 1.029 106.6 116.805 2.391 1.104 101.8 118.938 5.009 1.490 126.2 130.812 
20 3.111 1.133 118.1 119.792 7.550 1.397 126.1 127.912 9.736 1.724 131.9 139.417 
30 7.244 1.531 129.4 132.391 9.263 1.707 143.3 140.996 17.593 2.504 140.7 N/A 
60 11.109 1.931 145.1 148.086 9.970 1.423 140.4 128.612 41.835 3.648 114.0 N/A 
90 16.182 1.912 150.7 147.322 31.379 2.787 135.4 N/A 48.343 3.546 114.1 N/A 
120 19.715 2.407 151.9 N/A 37.192 3.110 131.5 N/A 90.812 6.014 112.2 N/A 
150 28.138 2.261 154.8 142.583 20.517 1.843 134.1 144.603     
180 39.572 3.476 133.5 N/A         
210 43.403 2.540 129.5 153.396         
240 44.440 2.497 133.2 160.902         
270 63.397 3.541 130.3 N/A         
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contact angles (θr) were calculated based on the roughness factor (r) and the contact angle of the 
unprocessed, neat CYTOP surface (θs) as it is described in Equation 5-1. In general, the 
calculated contact angle matched well with the measured static contact angle (Table 5-1 and 
Figure 5-6) when the surface was plasma-treated for a relatively short time (20 to 90 seconds, 
with the time depending on the RF power and the feed gas). However, as the surfaces were 
further roughened, the calculated contact angle did not match with the experimental value, and 
the roughness factor became so large (>2.278) that the contact angle could not be calculated. 
Because cosine cannot exceed ‗1‘ mathematically, the maximum roughness factor that can be 
applied to the Wenzel model with this plasma-treated CYTOP system was calculated to be 2.278, 
when θr is at its maximum value of 154.8º and θs is 113.4º. This means that the increase in the 
contact angle observed under the short etching time condition is actually due to an increase in 
surface area just as the Wenzel model describes: the liquid completely covers the surface and the 
increased roughness increases the contact angle. However, as the grain size becomes bigger 
(Figure 5-5), the water droplet leaves the Wenzel state as the Wenzel model fails to predict the 
contact angles correctly. This may indicate that at some point a Wenzel-Cassie transition occurs 
and as the nanostructures grow larger, the volume of air between the nanostructures is large 
enough to support a drop sitting on top of the peaks of the rough surface. This further increases 
the contact angle and in some cases (such as SF6-etched (100 W) CYTOP), generates 
superhydrophobic surfaces.   
After generating superhydrophobic surfaces, the levels of non-specific protein adsorption 
on theses substrates were investigated. A simple polydimethyl siloxane (PDMS) microfluidic 
channel was fabricated for this study, and after it was sealed on top of CYTOP substrates, 
AlexaFluor 647-labeled BSA was delivered through its microfluidic channel. BSA was chosen 
since serum albumin is one of the most abundant proteins in serum, and it is suitable for non-
specific adsorption experiment. As BSA travels through the channel, it interacts with CYTOP 
surfaces. Fluorescence microscopy images were taken after removing the PDMS mold from the 
CYTOP surface and the linear fluorescence profiles across the channel were obtained. Figure 5-7 
shows a few examples of these images. The result was that the BSA binding levels on all of the 
plasma-treated CYTOP surfaces were higher than the level observed on unprocessed CYTOP 
(Figure 5-7a).  In terms of contact angle, a neat CYTOP surface has the lowest contact angle, but 
it also has a low CAH that may reduce non-specific binding. However, CAH is not, the only  
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Figure 5-6. Comparison of measured (solid circle) and calculated (open circle) contact angles of 
surfaces treated by SF6 at 100W (a), O2 at 100W (b), or SF6 at 200W (c).  
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Figure 5-7. Fluorescent microscopy images (left column) and the fluorescence line scans (right 
column) of neat CYTOP (a), CYTOP O2-etched for 120 s. (b), and CYTOP SF6-etched for 120 s. 
(c). RIE power was 100 W for all the samples.  
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factor to affect the fouling of BSA. Even though water droplets strongly adhered to O2-etched 
surfaces, non-specific binding levels were similar or lower than the superhydrophobic surface 
prepared by SF6 etching. Thus the fluorescence imaging data does not support previous 
assumptions that superhydrophobicity and low CAH can improve the non-fouling properties of 
CYTOP surfaces. It seems that surface roughness, heterogeneity, hydrophobicity, CAH, and 
many other factors affect the fouling properties of plasma-processed perfluoropolymer surfaces, 
and therefore a much broader understanding of surface characteristics is needed to design and 
fabricate fouling-resistant interfaces. 
 
5.4. Conclusion 
The wetting properties of the perfluoropolymer, CYTOP, can be easily controlled by 
changing a few key parameters of the RIE etching process. With SF6 plasma, even 
superhydrophobic (contact angle higher than 150°) surfaces can be obtained. The Wenzel model 
and the measured contact angles were in good agreement when the surface roughness factors 
were relatively small.  Unlike static contact angles, however, CAHs were not improved over 
unprocessed neat CYTOP, which has a CAH of about 10°. Furthermore, protein non-specific 
adsorption experiments show that plasma treating CYTOP does not significantly improve the 
material’s non-fouling properties.  
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Chapter 6 
 
Future Works 
 
In this thesis, I have used silicon photonic microring resonators to monitor surface 
bioconjugation and evaluate the binding kinetics of various protein capture agents in parallel. In 
particular, I have shown that it is possible to evaluate the binding kinetics of up to three capture 
agents simultaneously. In the near future, however, the multiplexing capability of the microring 
resonator platform can be scaled up since microring chips are fabricated on silicon-on-insulator 
wafers by commercial CMOS (complementary metal-oxide semiconductor) processing taking 
advantage of low-cost, high scalability, and reproducibility. One 8‖ wafer generates hundreds of 
chips of single millimeter-scale, and the number of microrings on a given chip can be scaled up 
to several thousand. However, even with thousands of microrings on a single chip, high degrees 
of multiplexing cannot be achieved without a proper printing technique. It is essential to 
immobilize capture agents in such a way that individual or several rings are efficiently 
functionalized with each capture agent. We have tried a few different spotting and flow-based 
immobilization techniques in our group, and a microfluidic-based immobilization method has 
been found to be the most reproducible for protein functionalization. Therefore, the next step will 
be to develop or find highly multiplexed micorofluidics and utilize them.     
The ability to monitor the binding kinetics of multiple capture agents simultaneously will 
be of great utility in the high-throughput screening of capture agents. Furthermore, it can be 
applied to monitor any type of biomolecular interaction, so this technique will be useful in 
diseases diagnostics, drug screening, and biodefense applications.  
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